<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:32:25Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8222840" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8222840</identifier>
        <datestamp>2021-06-29</datestamp>
        <setSpec>jintaidssoc</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="brief-report">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">J Int AIDS Soc</journal-id>
              <journal-id journal-id-type="iso-abbrev">J Int AIDS Soc</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)1758-2652</journal-id>
              <journal-id journal-id-type="publisher-id">JIA2</journal-id>
              <journal-title-group>
                <journal-title>Journal of the International AIDS Society</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1758-2652</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8222840</article-id>
              <article-id pub-id-type="pmcid">PMC8222840</article-id>
              <article-id pub-id-type="pmc-uid">8222840</article-id>
              <article-id pub-id-type="pmid">34164935</article-id>
              <article-id pub-id-type="doi">10.1002/jia2.25720</article-id>
              <article-id pub-id-type="publisher-id">JIA225720</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Short Report</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Supplement: Short Report</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Project Khanya: results from a pilot randomized type 1 hybrid effectiveness‐implementation trial of a peer‐delivered behavioural intervention for ART adherence and substance use in HIV care in South Africa</article-title>
                <alt-title alt-title-type="left-running-head">Magidson JF et al.</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="jia225720-cr-0001" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Magidson</surname>
                    <given-names>Jessica F</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3513-3255</contrib-id>
                  <xref ref-type="aff" rid="jia225720-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <address>
                    <email>jmagidso@umd.edu</email>
                  </address>
                </contrib>
                <contrib id="jia225720-cr-0002" contrib-type="author">
                  <name>
                    <surname>Joska</surname>
                    <given-names>John A</given-names>
                  </name>
                  <address>
                    <email>john.joska@uct.ac.za</email>
                  </address>
                  <xref ref-type="aff" rid="jia225720-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jia225720-cr-0003" contrib-type="author">
                  <name>
                    <surname>Belus</surname>
                    <given-names>Jennifer M</given-names>
                  </name>
                  <address>
                    <email>jennifer.belus@swisstph.ch</email>
                  </address>
                  <xref ref-type="aff" rid="jia225720-aff-0001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jia225720-cr-0004" contrib-type="author">
                  <name>
                    <surname>Andersen</surname>
                    <given-names>Lena S</given-names>
                  </name>
                  <address>
                    <email>lena.andersen@sund.ku.dk</email>
                  </address>
                  <xref ref-type="aff" rid="jia225720-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jia225720-cr-0005" contrib-type="author">
                  <name>
                    <surname>Regenauer</surname>
                    <given-names>Kristen S</given-names>
                  </name>
                  <address>
                    <email>kregenau@terpmail.umd.edu</email>
                  </address>
                  <xref ref-type="aff" rid="jia225720-aff-0001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jia225720-cr-0006" contrib-type="author">
                  <name>
                    <surname>Rose</surname>
                    <given-names>Alexandra L</given-names>
                  </name>
                  <address>
                    <email>alrose@umd.edu</email>
                  </address>
                  <xref ref-type="aff" rid="jia225720-aff-0001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jia225720-cr-0007" contrib-type="author">
                  <name>
                    <surname>Myers</surname>
                    <given-names>Bronwyn</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0235-6716</contrib-id>
                  <address>
                    <email>bronwyn.myers@mrc.ac.za</email>
                  </address>
                  <xref ref-type="aff" rid="jia225720-aff-0003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jia225720-cr-0008" contrib-type="author">
                  <name>
                    <surname>Majokweni</surname>
                    <given-names>Sybil</given-names>
                  </name>
                  <address>
                    <email>sybil.majokweni@uct.ac.za</email>
                  </address>
                  <xref ref-type="aff" rid="jia225720-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jia225720-cr-0009" contrib-type="author">
                  <name>
                    <surname>O’Cleirigh</surname>
                    <given-names>Conall</given-names>
                  </name>
                  <address>
                    <email>coleirigh@mgh.harvard.edu</email>
                  </address>
                  <xref ref-type="aff" rid="jia225720-aff-0004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="jia225720-cr-0010" contrib-type="author">
                  <name>
                    <surname>Safren</surname>
                    <given-names>Steven A</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0121-0806</contrib-id>
                  <address>
                    <email>ssafren@miami.edu</email>
                  </address>
                  <xref ref-type="aff" rid="jia225720-aff-0005">
                    <sup>5</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="jia225720-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">Department of Psychology</named-content>
                <institution>University of Maryland</institution>
                <city>College Park</city>
                <named-content content-type="country-part">MD</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jia225720-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">HIV Mental Health Research Unit</named-content>
                <named-content content-type="organisation-division">Division of Neuropsychiatry</named-content>
                <named-content content-type="organisation-division">Department of Psychiatry and Mental Health</named-content>
                <institution>Groote Schuur Hospital</institution>
                <city>Cape Town</city>
                <country country="ZA">South Africa</country>
              </aff>
              <aff id="jia225720-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <named-content content-type="organisation-division">Alcohol, Tobacco and Other Drug Research Unit</named-content>
                <named-content content-type="organisation-division">South African Medical Research Council</named-content>
                <named-content content-type="organisation-division">Division of Addiction Psychiatry</named-content>
                <named-content content-type="organisation-division">Department of Psychiatry and Mental Health</named-content>
                <institution>University of Cape Town</institution>
                <city>Cape Town</city>
                <country country="ZA">South Africa</country>
              </aff>
              <aff id="jia225720-aff-0004">
                <label>
                  <sup>4</sup>
                </label>
                <named-content content-type="organisation-division">Department of Psychiatry</named-content>
                <institution>Massachusetts General Hospital/Harvard Medical School</institution>
                <city>Boston</city>
                <named-content content-type="country-part">MA</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jia225720-aff-0005">
                <label>
                  <sup>5</sup>
                </label>
                <named-content content-type="organisation-division">Department of Psychology</named-content>
                <institution>University of Miami</institution>
                <city>Miami</city>
                <named-content content-type="country-part">FL</named-content>
                <country country="US">USA</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label><bold>Corresponding author</bold>: Jessica F Magidson, University of Maryland, 4094 Campus Drive, College Park, Maryland, USA. Tel: +301‐405‐5095. (<email>jmagidso@umd.edu</email>)<break/></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>24</day>
                <month>6</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>6</month>
                <year>2021</year>
              </pub-date>
              <volume>24</volume>
              <issue>Suppl 2</issue>
              <issue-id pub-id-type="doi">10.1002/jia2.v24.s2</issue-id>
              <issue-title content-type="special-issue-title">Global Mental Health and HIV Prevention and Care. Guest Editors: Robert H Remien, Melanie Amna Abas, Vikram Patel, Dixon Chibanda</issue-title>
              <elocation-id>e25720</elocation-id>
              <history>
                <date date-type="rev-recd">
                  <day>31</day>
                  <month>3</month>
                  <year>2021</year>
                </date>
                <date date-type="received">
                  <day>07</day>
                  <month>10</month>
                  <year>2020</year>
                </date>
                <date date-type="accepted">
                  <day>08</day>
                  <month>4</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <!--<copyright-statement content-type="issue-copyright">&#x000a9; 2021 International AIDS Society<copyright-statement>-->
                <copyright-statement content-type="article-copyright">© 2021 The Authors. Journal of the International AIDS Society published by John Wiley &amp; Sons Ltd on behalf of the International AIDS Society.</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="file:JIA2-24-e25720.pdf"/>
              <abstract id="jia225720-abs-0001">
                <title>Abstract</title>
                <sec id="jia225720-sec-0001">
                  <title>Introduction</title>
                  <p>South Africa (SA) has the highest number of people living with HIV (PLWH) globally, and a significant burden of alcohol and other drug use (AOD). Although integrating AOD treatment into HIV care may improve antiretroviral therapy (ART) adherence, this is not typically routine practice in SA or other low‐resource settings. Identifying interventions that are feasible and acceptable for implementation is critical to improve HIV and AOD outcomes.</p>
                </sec>
                <sec id="jia225720-sec-0002">
                  <title>Methods</title>
                  <p>A pilot randomized hybrid type 1 effectiveness‐implementation trial (<italic>N</italic> = 61) was conducted to evaluate the feasibility and acceptability of <italic>Khanya</italic>, a task‐shared, peer‐delivered behavioral intervention to improve ART adherence and reduce AOD in HIV care in SA. <italic>Khanya</italic> was compared to enhanced treatment as usual (ETAU), a facilitated referral to on‐site AOD treatment. Implementation outcomes, defined by Proctor’s model, included feasibility, acceptability, appropriateness and fidelity. Primary pilot effectiveness outcomes were ART adherence at post‐treatment (three months) measured via real‐time electronic adherence monitoring, and AOD measured using biomarker and self‐report assessments over six months. Data collection was conducted from August 2018 to April 2020.</p>
                </sec>
                <sec id="jia225720-sec-0003">
                  <title>Results and discussion</title>
                  <p>Ninety‐one percent of participants (<italic>n</italic> = 56) were retained at six months. The intervention was highly feasible, acceptable, appropriate and delivered with fidelity (&gt;90% of components delivered as intended by the peer). There was a significant treatment‐by‐time interaction for ART adherence (estimate = −0.287 [95% CI = −0.507, −0.066]), revealing a 6.4 percentage point increase in ART adherence in <italic>Khanya</italic>, and a 22.3 percentage point decline in ETAU. Both groups evidenced significant reductions in alcohol use measured using phosphatidylethanol (PEth) (<italic>F</italic>(2,101) = 4.16, <italic>p</italic> = 0.01), significantly decreased likelihood of self‐reported moderate or severe AOD (<italic>F</italic>(2,104) = 7.02, <italic>p</italic> = 0.001), and significant declines in alcohol use quantity on the timeline follow‐back (<italic>F</italic>(2,102) = 21.53, <italic>p</italic> &lt; 0.001). Among individuals using drugs and alcohol, there was a greater reduction in alcohol use quantity in <italic>Khanya</italic> compared to ETAU over six months (<italic>F</italic>(2,31) = 3.28, <italic>p</italic> = 0.05).</p>
                </sec>
                <sec id="jia225720-sec-0004">
                  <title>Conclusions</title>
                  <p>Results of this pilot trial provide initial evidence of the feasibility and acceptability of the <italic>Khanya</italic> intervention for improving adherence in an underserved group at high risk for ongoing ART non‐adherence and HIV transmission. Implementation results suggest that peers may be a potential strategy to extend task‐sharing models for behavioral health in resource‐limited, global settings.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd id="jia225720-kwd-0001">HIV</kwd>
                <kwd id="jia225720-kwd-0002">substance use</kwd>
                <kwd id="jia225720-kwd-0003">antiretroviral therapy adherence</kwd>
                <kwd id="jia225720-kwd-0004">global mental health</kwd>
                <kwd id="jia225720-kwd-0005">implementation science</kwd>
                <kwd id="jia225720-kwd-0006">South Africa</kwd>
              </kwd-group>
              <funding-group>
                <award-group id="funding-0001">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Institute of Mental Health </institution>
                      <institution-id institution-id-type="open-funder-registry">10.13039/100000025</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>R01MH103770</award-id>
                </award-group>
                <award-group id="funding-0002">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Institute on Drug Abuse </institution>
                      <institution-id institution-id-type="open-funder-registry">10.13039/100000026</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>K23DA041901</award-id>
                  <award-id>K24DA040489</award-id>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="1"/>
                <table-count count="3"/>
                <page-count count="8"/>
                <word-count count="6868"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>June 2021</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.0.2 mode:remove_FC converted:24.06.2021</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <p content-type="self-citation">
                <mixed-citation publication-type="journal" id="jia225720-cit-1001"><string-name><surname>Magidson</surname>, <given-names>J. F.</given-names></string-name>, <string-name><surname>Joska</surname>, <given-names>J. A.</given-names></string-name>, <string-name><surname>Belus</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Andersen</surname>, <given-names>L. S.</given-names></string-name>, <string-name><surname>Regenauer</surname>, <given-names>K. S.</given-names></string-name>, <string-name><surname>Rose</surname>, <given-names>A. L.</given-names></string-name>, <string-name><surname>Myers</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Majokweni</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>O’Cleirigh</surname>, <given-names>C.</given-names></string-name> and <string-name><surname>Safren</surname>, <given-names>S. A.</given-names></string-name>
<article-title>Project Khanya: Results from a pilot randomized type 1 hybrid effectiveness‐implementation trial of a peer‐delivered behavioural intervention for ART adherence and substance use in HIV care in South Africa</article-title>. <source xml:lang="en">J Int AIDS Soc</source>. <year>2021</year>; <volume>24</volume>(S2):<elocation-id>e25720</elocation-id>
</mixed-citation>
              </p>
              <fn-group id="jia225720-ntgp-0001">
                <fn id="jia225720-note-0001">
                  <p>ClinicalTrials.gov identifier: NCT03529409. Trial registered on May 18, 2018.</p>
                </fn>
              </fn-group>
            </notes>
          </front>
          <body id="jia225720-body-0001">
            <sec id="jia225720-sec-0005">
              <label>1</label>
              <title>Introduction</title>
              <p>South Africa (SA) is home to the largest number of people living with HIV (PLWH) globally [<xref rid="jia225720-bib-0001" ref-type="ref">1</xref>]. Despite a large antiretroviral therapy (ART) programme, limited ART regimens are readily available in the public health sector [<xref rid="jia225720-bib-0002" ref-type="ref">2</xref>]. ART non adherence increases the risk of developing drug resistance and treatment failure, contributing to ongoing viral transmission, morbidity and mortality [<xref rid="jia225720-bib-0003" ref-type="ref">3</xref>, <xref rid="jia225720-bib-0004" ref-type="ref">4</xref>].</p>
              <p>Alongside the HIV epidemic, alcohol and other drug use (AOD) are highly prevalent among PLWH in SA [<xref rid="jia225720-bib-0005" ref-type="ref">5</xref>, <xref rid="jia225720-bib-0006" ref-type="ref">6</xref>]. Individuals with AOD are at greater risk for poor ART adherence, viral non‐suppression, and ongoing HIV transmission [<xref rid="jia225720-bib-0007" ref-type="ref">7</xref>, <xref rid="jia225720-bib-0008" ref-type="ref">8</xref>, <xref rid="jia225720-bib-0009" ref-type="ref">9</xref>, <xref rid="jia225720-bib-0010" ref-type="ref">10</xref>, <xref rid="jia225720-bib-0011" ref-type="ref">11</xref>, <xref rid="jia225720-bib-0012" ref-type="ref">12</xref>, <xref rid="jia225720-bib-0013" ref-type="ref">13</xref>, <xref rid="jia225720-bib-0014" ref-type="ref">14</xref>]. Integrating AOD treatment into HIV care can improve ART adherence, yet this is not typically routine practice in SA or other low‐resource settings [<xref rid="jia225720-bib-0015" ref-type="ref">15</xref>, <xref rid="jia225720-bib-0016" ref-type="ref">16</xref>, <xref rid="jia225720-bib-0017" ref-type="ref">17</xref>]. Furthermore, ART adherence interventions are rarely adapted for AOD – a missed opportunity for maximizing HIV treatment outcomes [<xref rid="jia225720-bib-0018" ref-type="ref">18</xref>, <xref rid="jia225720-bib-0019" ref-type="ref">19</xref>, <xref rid="jia225720-bib-0020" ref-type="ref">20</xref>, <xref rid="jia225720-bib-0021" ref-type="ref">21</xref>, <xref rid="jia225720-bib-0022" ref-type="ref">22</xref>, <xref rid="jia225720-bib-0023" ref-type="ref">23</xref>].</p>
              <p>We conducted a hybrid type 1 effectiveness‐implementation [<xref rid="jia225720-bib-0024" ref-type="ref">24</xref>] pilot study to evaluate the feasibility, acceptability, appropriateness and fidelity of a peer‐delivered intervention (“<italic>Khanya</italic>”), and preliminarily examine whether <italic>Khanya</italic> was associated with improvements in ART adherence over three months and AOD over six months versus enhanced treatment as usual (ETAU) [<xref rid="jia225720-bib-0025" ref-type="ref">25</xref>, <xref rid="jia225720-bib-0026" ref-type="ref">26</xref>].</p>
            </sec>
            <sec sec-type="methods" id="jia225720-sec-0006">
              <label>2</label>
              <title>Methods</title>
              <sec id="jia225720-sec-0007">
                <label>2.1</label>
                <title>Recruitment and screening</title>
                <p>Individuals were recruited between August 2018 and October 2019 from HIV care in Khayelitsha, a community with the highest HIV prevalence in the Western Cape [<xref rid="jia225720-bib-0027" ref-type="ref">27</xref>]. Inclusion criteria were as follows: (1) HIV positive and on ART; (2) 18 to 65 years old; (3) at least moderate AOD on the WHO Alcohol, Smoking, and Substance Involvement Screening Test (WHO‐ASSIST [<xref rid="jia225720-bib-0028" ref-type="ref">28</xref>]); (4) ART non‐adherence in the past three months, defined by either: (a) missing a pharmacy refill; (b) reinitiating first‐line treatment or being on second‐line treatment or (c) having unsuppressed viral load (≥400 copies/mL). Exclusion criteria were as follows: (1) high‐risk opiate or alcohol use warranting medical management; (2) untreated major mental illness; (3) inability to provide informed consent or speak English or isiXhosa; (4) third‐trimester pregnancy or (5) currently enrolled in AOD treatment. Eligible and interested participants completed informed consent and baseline assessments. Participants were given a Wisepill device [<xref rid="jia225720-bib-0029" ref-type="ref">29</xref>] to monitor ART adherence over two weeks. At two‐weeks post‐baseline, participants were randomly assigned in parallel (1:1) to ETAU or <italic>Khanya</italic> using Research Electronic Data Capture (REDCap). Participants were assessed by a trained, blinded assessor at three‐ and six‐month post‐baseline. Participants received a 150ZAR (approximately $10 USD) grocery voucher for completing study assessments. All procedures were approved by the University of Cape Town Health Sciences Faculty Human Research Ethics Committee (HREC 187/2018). Magidson <italic>et al</italic>.[<xref rid="jia225720-bib-0030" ref-type="ref">30</xref>] includes full protocol details.</p>
              </sec>
              <sec id="jia225720-sec-0008">
                <label>2.2</label>
                <title>Allocation groups</title>
                <sec id="jia225720-sec-0009">
                  <label>2.2.1</label>
                  <title>Khanya</title>
                  <p>Khanya is a six‐session peer‐delivered behavioral intervention that integrates several evidence‐based intervention components [<xref rid="jia225720-bib-0031" ref-type="ref">31</xref>, <xref rid="jia225720-bib-0032" ref-type="ref">32</xref>, <xref rid="jia225720-bib-0033" ref-type="ref">33</xref>, <xref rid="jia225720-bib-0034" ref-type="ref">34</xref>] – behavioral activation, problem solving, motivational interviewing and mindfulness‐based relapse prevention – adapted during formative work preceding this trial [<xref rid="jia225720-bib-0035" ref-type="ref">35</xref>, <xref rid="jia225720-bib-0036" ref-type="ref">36</xref>]. The intervention aims to support increased ART adherence and individualized goal setting for AOD reduction by teaching evidence‐based behavioral skills (i.e. behavioral monitoring, activity scheduling, mindfulness practice, relapse prevention) to support the attainment of these goals. Home practice is assigned between sessions to reinforce skills. Real‐time electronic adherence monitoring is discussed in session in relation to skill practice to address barriers to adherence and relapse prevention. Participants are offered up to six optional booster sessions to further reinforce skills. Participants were not compensated for intervention sessions but travel costs were reimbursed. Sessions lasted approximately 60 minutes. The interventionist was a peer – an individual with lived AOD experience – paid full‐time as part of the research team, trained and supervised by clinical psychologists. Intervention, supervision and training details are provided elsewhere [<xref rid="jia225720-bib-0030" ref-type="ref">30</xref>, <xref rid="jia225720-bib-0037" ref-type="ref">37</xref>].</p>
                </sec>
                <sec id="jia225720-sec-0010">
                  <label>2.2.2</label>
                  <title>Enhanced treatment as usual</title>
                  <p>TAU for individuals with AOD in this context is a referral letter to Matrix [<xref rid="jia225720-bib-0038" ref-type="ref">38</xref>, <xref rid="jia225720-bib-0039" ref-type="ref">39</xref>], an evidence‐based, co‐located 16‐week AOD programme that includes an initial screening and brief intervention session [<xref rid="jia225720-bib-0025" ref-type="ref">25</xref>, <xref rid="jia225720-bib-0026" ref-type="ref">26</xref>]. We enhanced TAU by discussing the referral to Matrix, offering to accompany participants to the intake if they wished, and following up on referral uptake at subsequent visits.</p>
                </sec>
              </sec>
              <sec id="jia225720-sec-0011">
                <label>2.3</label>
                <title>Measures</title>
                <p>Implementation outcomes were guided by Proctor’s model [<xref rid="jia225720-bib-0040" ref-type="ref">40</xref>], including feasibility, acceptability, appropriateness and fidelity. <italic>Feasibility</italic> and <italic>acceptability</italic> were assessed based on uptake (percentage who initiated the intervention and session attendance respectively) and a validated quantitative measure was used for assessing implementation outcomes in Low‐and‐middle‐income countries (LMICs) [<xref rid="jia225720-bib-0041" ref-type="ref">41</xref>], including feasibility, acceptability and appropriateness (ratings on a four‐point scale: 0 = “not at all”; 3 = “a lot”). <italic>Fidelity</italic>. A randomly selected 20% of <italic>Khanya</italic> sessions were rated by the interventionist and an independent coder (trained in fidelity monitoring and not involved in this study) following best practices and other studies examining fidelity of task‐shared interventions [<xref rid="jia225720-bib-0042" ref-type="ref">42</xref>]. A 15 to 19 item (depending on session) checklist of core session components was developed a priori. The independent coder also rated common factors (i.e. verbal communication, self‐disclosure, normalization, empathy) using the ENhancing Assessment of Common Therapeutic factors (ENACT; 1 to 3 rating scale) [<xref rid="jia225720-bib-0043" ref-type="ref">43</xref>].</p>
                <p>ART adherence was assessed from baseline (past two weeks) through post‐treatment (approximately three months) using Wisepill, a real‐time adherence monitoring device [<xref rid="jia225720-bib-0029" ref-type="ref">29</xref>]. Adherence was measured as the percentage of days’ adherent from baseline to the week prior to post‐treatment. Observations, where the device battery was dysfunctional, were excluded.</p>
                <p>AOD was assessed using biomarker and self‐report at baseline, three months and six months. <italic>Phosphatidylethanol (PEth)</italic> testing was conducted from dried blood spots (≥50 ng/mL reflects unhealthy drinking up to 21 days [<xref rid="jia225720-bib-0044" ref-type="ref">44</xref>]). <italic>Urinalysis</italic> assessed cocaine, marijuana, amphetamines, opiates, phencyclidine and alcohol (&lt;80 hours; 300 ng/mL; [<xref rid="jia225720-bib-0045" ref-type="ref">45</xref>, <xref rid="jia225720-bib-0046" ref-type="ref">46</xref>]), and methaqualone (Mandrax), a local sedative. The <italic>WHO‐ASSIST</italic> assessed past three‐month self‐reported AOD [<xref rid="jia225720-bib-0028" ref-type="ref">28</xref>] using defined risk categories (<italic>alcohol</italic>: ≥27 high risk; 11 to 26 moderate; 0 to 10 low; <italic>drugs</italic>: ≥27 high risk; 4 to 26 moderate; 0 to 3 low). The <italic>Timeline Follow‐Back (TLFB)</italic> [<xref rid="jia225720-bib-0047" ref-type="ref">47</xref>], a calendar‐aided assessment of AOD, assessed the quantity of alcohol use in the past two weeks and the percentage of days used (any substance). Recall was aided by the use of empty, locally recognizable alcohol containers.</p>
                <p>Viral load (exploratory) was extracted from medical records (within three months before baseline, 30 days of follow‐ups) or drawn and tested by the National Health Laboratory Service when unavailable. Viral suppression was defined as &lt;400 copies/mL per local clinic standards.</p>
              </sec>
              <sec id="jia225720-sec-0012">
                <label>2.4</label>
                <title>Data analytic plan</title>
                <p>This pilot study aimed to establish the feasibility and acceptability of <italic>Khanya</italic>, examined using descriptive statistics (means and standard deviations) of implementation outcomes. The study sample size followed recommendations for pilot studies [<xref rid="jia225720-bib-0048" ref-type="ref">48</xref>, <xref rid="jia225720-bib-0049" ref-type="ref">49</xref>]. Effectiveness outcomes were examined using multilevel modelling to account for repeated measurements [<xref rid="jia225720-bib-0050" ref-type="ref">50</xref>]. Time was treated categorically to capture differing rates of change between time points, and all models included a random intercept. Analyses used an intent‐to‐treat framework [<xref rid="jia225720-bib-0051" ref-type="ref">51</xref>], including all available data. Missing data were treated as missing at random. All analyses were run using SAS version 9.4 [<xref rid="jia225720-bib-0052" ref-type="ref">52</xref>]. Presented models were adjusted for baseline age and gender, determined a priori [<xref rid="jia225720-bib-0030" ref-type="ref">30</xref>], and observed baseline differences in theoretically relevant factors (relationship status, viral suppression and substance use severity). As sensitivity analyses, models were re‐run without covariates and with age and gender only. Models were also run with time treated continuously and a random slope. The pattern of results for sensitivity analyses did not differ. We also examined all results separately for a subsample who also used drugs in the past three months (<italic>n</italic> = 21). See supplemental materials for the more detailed data analytic plan.</p>
              </sec>
            </sec>
            <sec id="jia225720-sec-0013">
              <label>3</label>
              <title>Results and Discussion</title>
              <sec id="jia225720-sec-0014">
                <label>3.1</label>
                <title>Participants</title>
                <p>A total of <italic>N</italic> = 61 participants were enrolled and randomized; see Figure <xref rid="jia225720-fig-0001" ref-type="fig">1</xref> for consort diagram. The sample was largely Black African and 54% female. Individuals were ART adherent 51.4% of days over two weeks at baseline, over 80% had unhealthy drinking, and approximately one‐third had current drug use. Table <xref rid="jia225720-tbl-0001" ref-type="table">1</xref> includes baseline characteristics, and Table <xref rid="jia225720-tbl-0002" ref-type="table">2</xref> includes all outcomes by treatment group by time point.</p>
                <fig fig-type="Figure" xml:lang="en" id="jia225720-fig-0001" orientation="portrait" position="float">
                  <label>Figure 1</label>
                  <caption>
                    <p>Consort diagram.</p>
                    <p><sup>a</sup>WHO‐ASSIST too low only (n = 54); not struggling with adherence only (n = 1); WHO‐ASSIST too low and not struggling with adherence (n = 1); undertreated major mental illness (n = 2); incomplete screening (n = 1). <sup>b</sup>1 participant excluded pre‐randomization for severe alcohol dependence (medical management of withdrawal symptoms needed). <sup>c</sup>Participants uncontactable for specific event, but attended later events. <sup>d</sup>1 participant was uncontactable for remainder of study. <sup>e</sup>Due to staffing resource restraints, only 36/52 assessments were blinded at post‐treatment (69%), and only 19/56 assessments were blinded at six‐month follow‐up (34%).</p>
                  </caption>
                  <graphic id="jats-graphic-1" xlink:href="JIA2-24-e25720-g001"/>
                </fig>
                <table-wrap id="jia225720-tbl-0001" xml:lang="en" content-type="Table" orientation="portrait" position="float">
                  <label>Table 1</label>
                  <caption>
                    <p>Baseline demographic and clinical characteristics of sample by treatment group</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="top">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="top" rowspan="1" colspan="1">Characteristic</th>
                        <th align="center" valign="top" rowspan="1" colspan="1">Total sample (<italic>N</italic> = 61)</th>
                        <th align="center" valign="top" rowspan="1" colspan="1">Khanya (<italic>n</italic> = 30)</th>
                        <th align="center" valign="top" rowspan="1" colspan="1">ETAU (<italic>n</italic> = 31)</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Age, <italic>M</italic> (SD)</td>
                        <td align="center" rowspan="1" colspan="1">37.00 (9.63)</td>
                        <td align="center" rowspan="1" colspan="1">39.80 (10.47)</td>
                        <td align="center" rowspan="1" colspan="1">34.29 (7.99)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">% Female (n)</td>
                        <td align="center" rowspan="1" colspan="1">54.1 (33)</td>
                        <td align="center" rowspan="1" colspan="1">43.3 (13)</td>
                        <td align="center" rowspan="1" colspan="1">64.5 (20)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">% Graduated high school or above (n)</td>
                        <td align="center" rowspan="1" colspan="1">23.0 (14)</td>
                        <td align="center" rowspan="1" colspan="1">26.7 (8)</td>
                        <td align="center" rowspan="1" colspan="1">19.4 (6)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">% Casual or full‐time employment (n)</td>
                        <td align="center" rowspan="1" colspan="1">21.3 (13)</td>
                        <td align="center" rowspan="1" colspan="1">13.3 (4)</td>
                        <td align="center" rowspan="1" colspan="1">29.0 (9)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">% Married or common‐law (n)</td>
                        <td align="center" rowspan="1" colspan="1">26.2 (16)</td>
                        <td align="center" rowspan="1" colspan="1">10.0 (3)</td>
                        <td align="center" rowspan="1" colspan="1">41.9 (13)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">HIV characteristics</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Years since HIV diagnosis, <italic>M</italic> (SD)</td>
                        <td align="center" rowspan="1" colspan="1">6.27 (4.87)</td>
                        <td align="center" rowspan="1" colspan="1">7.14 (5.97)</td>
                        <td align="center" rowspan="1" colspan="1">5.43 (3.39)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">% Suppressed viral load (&lt;400 copies/mL) (n)</td>
                        <td align="center" rowspan="1" colspan="1">63.9 (39)</td>
                        <td align="center" rowspan="1" colspan="1">50.0 (15)</td>
                        <td align="center" rowspan="1" colspan="1">77.4 (24)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">CD4 count</td>
                        <td align="center" rowspan="1" colspan="1">376 (253)</td>
                        <td align="center" rowspan="1" colspan="1">330 (210)</td>
                        <td align="center" rowspan="1" colspan="1">420 (285)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">% Days adherent via Wisepill over two weeks, <italic>M</italic> (SD)<xref ref-type="fn" rid="jia225720-note-0002"><sup>a</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">51.4 (30.7)</td>
                        <td align="center" rowspan="1" colspan="1">53.6 (32.1)</td>
                        <td align="center" rowspan="1" colspan="1">49.3 (29.7)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">% On second‐line (n)<xref ref-type="fn" rid="jia225720-note-0003"><sup>b</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">26.7 (16)</td>
                        <td align="center" rowspan="1" colspan="1">24.1 (7)</td>
                        <td align="center" rowspan="1" colspan="1">29.0 (9)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">Substance use characteristics</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">% Positive alcohol urine test (n)</td>
                        <td align="center" rowspan="1" colspan="1">88.5 (54)</td>
                        <td align="center" rowspan="1" colspan="1">86.7 (26)</td>
                        <td align="center" rowspan="1" colspan="1">90.3 (28)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">% PEth unhealthy drinking (n)</td>
                        <td align="center" rowspan="1" colspan="1">83.6 (51)</td>
                        <td align="center" rowspan="1" colspan="1">90.0 (27)</td>
                        <td align="center" rowspan="1" colspan="1">77.4 (24)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">WHO‐ASSIST alcohol score, <italic>M</italic> (SD)<xref ref-type="fn" rid="jia225720-note-0004"><sup>c</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">25.66 (6.88)</td>
                        <td align="center" rowspan="1" colspan="1">25.93 (6.70)</td>
                        <td align="center" rowspan="1" colspan="1">25.39 (7.16)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">% Days consumed any substance on TLFB, <italic>M</italic> (SD)</td>
                        <td align="center" rowspan="1" colspan="1">34.1 (23.5)</td>
                        <td align="center" rowspan="1" colspan="1">38.8 (24.6)</td>
                        <td align="center" rowspan="1" colspan="1">29.5 (21.7)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">% Days consumed alcohol on TLFB, <italic>M</italic> (SD)</td>
                        <td align="center" rowspan="1" colspan="1">30.3 (21.0)</td>
                        <td align="center" rowspan="1" colspan="1">37.1 (22.9)</td>
                        <td align="center" rowspan="1" colspan="1">23.7 (16.9)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Average number of drinks on days drinking on TLFB, <italic>M</italic> (SD)</td>
                        <td align="center" rowspan="1" colspan="1">7.60 (4.75)</td>
                        <td align="center" rowspan="1" colspan="1">7.17 (3.79)</td>
                        <td align="center" rowspan="1" colspan="1">8.03 (5.59)<xref ref-type="fn" rid="jia225720-note-0005"><sup>d</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">% Positive (any) drug urine test (n)</td>
                        <td align="center" rowspan="1" colspan="1">31.2 (19)</td>
                        <td align="center" rowspan="1" colspan="1">40.0 (12)</td>
                        <td align="center" rowspan="1" colspan="1">22.6 (7)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">WHO‐ASSIST (any) drug score, <italic>M</italic> (SD)<xref ref-type="fn" rid="jia225720-note-0006"><sup>e</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">13.10 (9.47)</td>
                        <td align="center" rowspan="1" colspan="1">9.25 (6.34)</td>
                        <td align="center" rowspan="1" colspan="1">15.67 (10.84)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">% Days consumed other drugs on TLFB, <italic>M</italic> (SD)<xref ref-type="fn" rid="jia225720-note-0007"><sup>f</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">39.8 (26.0)</td>
                        <td align="center" rowspan="1" colspan="1">47.6 (35.9)</td>
                        <td align="center" rowspan="1" colspan="1">33.9 (19.7)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jia225720-ntgp-0002">
                    <fn id="jia225720-note-0002">
                      <label>
                        <sup>a</sup>
                      </label>
                      <p>Data from randomization visit</p>
                    </fn>
                    <fn id="jia225720-note-0003">
                      <label>
                        <sup>b</sup>
                      </label>
                      <p>n = 29 for Khanya arm</p>
                    </fn>
                    <fn id="jia225720-note-0004">
                      <label>
                        <sup>c</sup>
                      </label>
                      <p>data from screening visit</p>
                    </fn>
                    <fn id="jia225720-note-0005">
                      <label>
                        <sup>d</sup>
                      </label>
                      <p>n = 30</p>
                    </fn>
                    <fn id="jia225720-note-0006">
                      <label>
                        <sup>e</sup>
                      </label>
                      <p>score for those who reported using substance in past 3 months (N = 11 WHO ASSIST scores from 10 participants, n = 4 Khanya arm, n = 7 ETAU arm)</p>
                    </fn>
                    <fn id="jia225720-note-0007">
                      <label>
                        <sup>f</sup>
                      </label>
                      <p>Cannabis was the only substance reported at this assessment; n = 3 for Khanya arm, n = 4 or ETAU arm. TFLB, Timeline Follow‐Back; SD, Standard deviation</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
                <table-wrap id="jia225720-tbl-0002" xml:lang="en" content-type="Table" orientation="portrait" position="float">
                  <label>Table 2</label>
                  <caption>
                    <p>Sample means and percentages for primary outcomes at assessment time points by treatment group</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="bottom">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="2" valign="bottom" colspan="1">Outcome measure</th>
                        <th align="center" colspan="3" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Khanya</th>
                        <th align="center" colspan="3" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">ETAU</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="center" valign="bottom" rowspan="1" colspan="1">Baseline (<italic>N</italic> = 30)</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">Three‐month (<italic>N</italic> = 26)</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">Six‐month (<italic>N</italic> = 27)</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">Baseline (<italic>N</italic> = 31)</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">Three‐month (<italic>N</italic> = 26)</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">Six‐month (<italic>N</italic> = 29)</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">% Days adherent via Wisepill, <italic>M</italic>
<italic>(SD)</italic>
</td>
                        <td align="center" rowspan="1" colspan="1">53.6 (32.1)<xref ref-type="fn" rid="jia225720-note-0008"><sup>a</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">60.0 (37.1)<xref ref-type="fn" rid="jia225720-note-0009"><sup>b</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">–</td>
                        <td align="center" rowspan="1" colspan="1">49.3 (29.8)</td>
                        <td align="center" rowspan="1" colspan="1">28.2 (32.1)<xref ref-type="fn" rid="jia225720-note-0010"><sup>c</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">–</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">% (n) suppressed viral load, &lt;400 copies/mL</td>
                        <td align="center" rowspan="1" colspan="1">50.0 (15)</td>
                        <td align="center" rowspan="1" colspan="1">65.4 (17)</td>
                        <td align="center" rowspan="1" colspan="1">59.3 (16)</td>
                        <td align="center" rowspan="1" colspan="1">77.4 (24)</td>
                        <td align="center" rowspan="1" colspan="1">73.1 (19)</td>
                        <td align="center" rowspan="1" colspan="1">75.9 (22)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">PEth score, <italic>M</italic>
<italic>(SD)</italic>
</td>
                        <td align="center" rowspan="1" colspan="1">686.0 (639.9)</td>
                        <td align="center" rowspan="1" colspan="1">484.2 (398.7)</td>
                        <td align="center" rowspan="1" colspan="1">538.4 (554.4)<xref ref-type="fn" rid="jia225720-note-0011"><sup>d</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">456.1 (530.8)</td>
                        <td align="center" rowspan="1" colspan="1">414.7 (389.6)<xref ref-type="fn" rid="jia225720-note-0011"><sup>d</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">386.1 (392.6)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">% Positive alcohol or drug urine test <italic>(n)</italic>
</td>
                        <td align="center" rowspan="1" colspan="1">90.0 (27)</td>
                        <td align="center" rowspan="1" colspan="1">96.2 (25)</td>
                        <td align="center" rowspan="1" colspan="1">83.3 (20)</td>
                        <td align="center" rowspan="1" colspan="1">93.6 (29)</td>
                        <td align="center" rowspan="1" colspan="1">88.5 (23)</td>
                        <td align="center" rowspan="1" colspan="1">82.8 (24)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">% Moderate or high risk on WHO‐ASSIST</td>
                        <td align="center" rowspan="1" colspan="1">100 (30)</td>
                        <td align="center" rowspan="1" colspan="1">88.5 (23)</td>
                        <td align="center" rowspan="1" colspan="1">88.9 (24)</td>
                        <td align="center" rowspan="1" colspan="1">100 (31)</td>
                        <td align="center" rowspan="1" colspan="1">96.2 (25)</td>
                        <td align="center" rowspan="1" colspan="1">75.9 (22)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">% Days consumed any substance on TLFB, <italic>M</italic>
<italic>(SD)</italic>
</td>
                        <td align="center" rowspan="1" colspan="1">38.8 (24.6)</td>
                        <td align="center" rowspan="1" colspan="1">29.1 (24.6)</td>
                        <td align="center" rowspan="1" colspan="1">30.7 (25.9)</td>
                        <td align="center" rowspan="1" colspan="1">29.5 (21.7)</td>
                        <td align="center" rowspan="1" colspan="1">24.5 (20.2)</td>
                        <td align="center" rowspan="1" colspan="1">25.1 (23.2)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Average number of drinks on days drinking on TLFB, <italic>M</italic>
<italic>(SD)</italic>
</td>
                        <td align="center" rowspan="1" colspan="1">7.17 (3.79)</td>
                        <td align="center" rowspan="1" colspan="1">5.36 (3.84)</td>
                        <td align="center" rowspan="1" colspan="1">4.61 (3.29)</td>
                        <td align="center" rowspan="1" colspan="1">8.03 (5.59)<xref ref-type="fn" rid="jia225720-note-0012"><sup>e</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">5.47 (3.77)<xref ref-type="fn" rid="jia225720-note-0011"><sup>d</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">4.96 (4.25)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jia225720-ntgp-0003">
                    <fn id="jia225720-note-0008">
                      <label>
                        <sup>a</sup>
                      </label>
                      <p><italic>n</italic> = 29</p>
                    </fn>
                    <fn id="jia225720-note-0009">
                      <label>
                        <sup>b</sup>
                      </label>
                      <p><italic>n</italic> = 28</p>
                    </fn>
                    <fn id="jia225720-note-0010">
                      <label>
                        <sup>c</sup>
                      </label>
                      <p><italic>n</italic> = 27</p>
                    </fn>
                    <fn id="jia225720-note-0011">
                      <label>
                        <sup>d</sup>
                      </label>
                      <p><italic>n</italic> = 25</p>
                    </fn>
                    <fn id="jia225720-note-0012">
                      <label>
                        <sup>e</sup>
                      </label>
                      <p><italic>n</italic> = 30. SD, standard deviation; TLFB, Timeline Follow‐Back</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
              </sec>
              <sec id="jia225720-sec-0015">
                <label>3.2</label>
                <title>Outcomes</title>
                <sec id="jia225720-sec-0016">
                  <label>3.2.1</label>
                  <title>Implementation outcomes</title>
                  <p>Although AOD treatment utilization is typically low in SA [<xref rid="jia225720-bib-0053" ref-type="ref">53</xref>], treatment uptake was high in this sample. Of the participants randomized to <italic>Khanya</italic>, 100% initiated the intervention, and 70% attended all six sessions (<italic>M</italic> = 4.77; <italic>SD</italic> = 1.96); 88% of <italic>Khanya</italic> participants reported satisfaction with the number of treatment sessions. Feasibility, acceptability and appropriateness of <italic>Khanya</italic> were rated very highly (feasibility: <italic>M</italic> = 2.98; <italic>SD</italic> = 0.18; acceptability: <italic>M</italic> = 2.98; <italic>SD</italic> = 0.04; appropriateness: <italic>M</italic> = 2.94, <italic>SD</italic> = 0.09). For ETAU, 80.6% (<italic>n</italic> = 25) attended the Matrix referral, of whom 68% (<italic>n</italic> = 17) attended only one session (range 0 to 11). Interventionist self‐reported fidelity was 96.5% (S<italic>D</italic> = 7.2) for <italic>Khanya</italic>; average independent rater fidelity was 91.7% (<italic>SD</italic> = 13.3). Peer therapeutic common factors, such as warmth and non‐judgement, were rated highly using ENACT (<italic>M</italic> = 2.69; <italic>SD</italic> = 0.28).</p>
                </sec>
                <sec id="jia225720-sec-0017">
                  <label>3.2.2</label>
                  <title>Effectiveness outcomes</title>
                  <p>Overall model results for all effectiveness outcomes are presented in Table <xref rid="jia225720-tbl-0003" ref-type="table">3</xref>. Drug subsample results for all outcomes are in Tables <xref rid="jia225720-sup-0002" ref-type="supplementary-material">S1‐S6</xref>.</p>
                  <table-wrap id="jia225720-tbl-0003" xml:lang="en" content-type="Table" orientation="portrait" position="float">
                    <label>Table 3</label>
                    <caption>
                      <p>Overview of all model results by time and time by treatment interaction</p>
                    </caption>
                    <table frame="hsides" rules="groups">
                      <col style="border-right:solid 1px #000000" span="1"/>
                      <col style="border-right:solid 1px #000000" span="1"/>
                      <col style="border-right:solid 1px #000000" span="1"/>
                      <col style="border-right:solid 1px #000000" span="1"/>
                      <col style="border-right:solid 1px #000000" span="1"/>
                      <col style="border-right:solid 1px #000000" span="1"/>
                      <col style="border-right:solid 1px #000000" span="1"/>
                      <col style="border-right:solid 1px #000000" span="1"/>
                      <col style="border-right:solid 1px #000000" span="1"/>
                      <thead valign="top">
                        <tr style="border-bottom:solid 1px #000000">
                          <th align="left" style="border-bottom:solid 1px #000000" valign="top" rowspan="1" colspan="1"> </th>
                          <th align="center" colspan="4" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Time only (effect of Khanya on outcome)</th>
                          <th align="center" colspan="4" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Time by Treatment (effect of ETAU on outcome)</th>
                        </tr>
                        <tr style="border-bottom:solid 1px #000000">
                          <th align="left" valign="top" rowspan="1" colspan="1">Effect</th>
                          <th align="center" valign="top" rowspan="1" colspan="1">Estimate (SE) or DF</th>
                          <th align="center" valign="top" rowspan="1" colspan="1">95% CI</th>
                          <th align="center" valign="top" rowspan="1" colspan="1"><italic>F</italic> or <italic>t</italic>
</th>
                          <th align="center" valign="top" rowspan="1" colspan="1">
                            <italic>p</italic>
                          </th>
                          <th align="center" valign="top" rowspan="1" colspan="1">Estimate (SE) or DF</th>
                          <th align="center" valign="top" rowspan="1" colspan="1">95% CI</th>
                          <th align="center" valign="top" rowspan="1" colspan="1"><italic>F</italic> or <italic>t</italic>
</th>
                          <th align="center" valign="top" rowspan="1" colspan="1">
                            <italic>p</italic>
                          </th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Wisepill adherence</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">PT</td>
                          <td align="center" rowspan="1" colspan="1">0.064 (0.078)</td>
                          <td align="center" rowspan="1" colspan="1">[−0.092, 0.220]</td>
                          <td align="center" rowspan="1" colspan="1">0.82</td>
                          <td align="center" rowspan="1" colspan="1">0.41</td>
                          <td align="center" rowspan="1" colspan="1">−0.287 (0.110)</td>
                          <td align="center" rowspan="1" colspan="1">[−0.507, −0.066]</td>
                          <td align="center" rowspan="1" colspan="1">−2.61</td>
                          <td align="center" rowspan="1" colspan="1">0.01</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">FU</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">PEth</td>
                          <td align="center" rowspan="1" colspan="1">2, 101</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                          <td align="center" rowspan="1" colspan="1">4.16</td>
                          <td align="center" rowspan="1" colspan="1">0.01</td>
                          <td align="center" rowspan="1" colspan="1">2, 101</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                          <td align="center" rowspan="1" colspan="1">0.97</td>
                          <td align="center" rowspan="1" colspan="1">0.38</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">PT</td>
                          <td align="center" rowspan="1" colspan="1">−227 (80)</td>
                          <td align="center" rowspan="1" colspan="1">[−385, −69]</td>
                          <td align="center" rowspan="1" colspan="1">−2.85</td>
                          <td align="center" rowspan="1" colspan="1">0.005</td>
                          <td align="center" rowspan="1" colspan="1">157 (113)</td>
                          <td align="center" rowspan="1" colspan="1">[−67, 382]</td>
                          <td align="center" rowspan="1" colspan="1">1.39</td>
                          <td align="center" rowspan="1" colspan="1">0.16</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">FU</td>
                          <td align="center" rowspan="1" colspan="1">−169 (81)</td>
                          <td align="center" rowspan="1" colspan="1">[−329, −9]</td>
                          <td align="center" rowspan="1" colspan="1">−2.09</td>
                          <td align="center" rowspan="1" colspan="1">0.03</td>
                          <td align="center" rowspan="1" colspan="1">84 (111)</td>
                          <td align="center" rowspan="1" colspan="1">[−136, 304]</td>
                          <td align="center" rowspan="1" colspan="1">0.76</td>
                          <td align="center" rowspan="1" colspan="1">0.44</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Alcohol/drug urine test</td>
                          <td align="center" rowspan="1" colspan="1">2, 101</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                          <td align="center" rowspan="1" colspan="1">1.67</td>
                          <td align="center" rowspan="1" colspan="1">0.19</td>
                          <td align="center" rowspan="1" colspan="1">2, 101</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                          <td align="center" rowspan="1" colspan="1">0.59</td>
                          <td align="center" rowspan="1" colspan="1">0.55</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">PT</td>
                          <td align="center" rowspan="1" colspan="1">−1.14 (1.36)</td>
                          <td align="center" rowspan="1" colspan="1">[−3.85, 1.56]</td>
                          <td align="center" rowspan="1" colspan="1">−0.84</td>
                          <td align="center" rowspan="1" colspan="1">0.40</td>
                          <td align="center" rowspan="1" colspan="1">1.95 (1.79)</td>
                          <td align="center" rowspan="1" colspan="1">[−1.61, 5.50]</td>
                          <td align="center" rowspan="1" colspan="1">1.09</td>
                          <td align="center" rowspan="1" colspan="1">0.27</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">FU</td>
                          <td align="center" rowspan="1" colspan="1">0.80 (1.04)</td>
                          <td align="center" rowspan="1" colspan="1">[−1.26, 2.87]</td>
                          <td align="center" rowspan="1" colspan="1">0.77</td>
                          <td align="center" rowspan="1" colspan="1">0.44</td>
                          <td align="center" rowspan="1" colspan="1">0.71 (1.49)</td>
                          <td align="center" rowspan="1" colspan="1">[−2.24, 3.67]</td>
                          <td align="center" rowspan="1" colspan="1">0.48</td>
                          <td align="center" rowspan="1" colspan="1">0.63</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Categorical ASSIST</td>
                          <td align="center" rowspan="1" colspan="1">2, 104</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                          <td align="center" rowspan="1" colspan="1">7.02</td>
                          <td align="center" rowspan="1" colspan="1">0.001</td>
                          <td align="center" rowspan="1" colspan="1">2, 104</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                          <td align="center" rowspan="1" colspan="1">0.10</td>
                          <td align="center" rowspan="1" colspan="1">0.90</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">PT</td>
                          <td align="center" rowspan="1" colspan="1">−1.35 (0.67)</td>
                          <td align="center" rowspan="1" colspan="1">[−2.67, −0.03]</td>
                          <td align="center" rowspan="1" colspan="1">−2.03</td>
                          <td align="center" rowspan="1" colspan="1">0.04</td>
                          <td align="center" rowspan="1" colspan="1">0.25 (0.89)</td>
                          <td align="center" rowspan="1" colspan="1">[−1.51, 2.00]</td>
                          <td align="center" rowspan="1" colspan="1">0.28</td>
                          <td align="center" rowspan="1" colspan="1">0.77</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">FU</td>
                          <td align="center" rowspan="1" colspan="1">−1.68 (0.66)</td>
                          <td align="center" rowspan="1" colspan="1">[−2.98, −0.37]</td>
                          <td align="center" rowspan="1" colspan="1">−2.55</td>
                          <td align="center" rowspan="1" colspan="1">0.01</td>
                          <td align="center" rowspan="1" colspan="1">−0.14 (0.87)</td>
                          <td align="center" rowspan="1" colspan="1">[−1.85, 1.58]</td>
                          <td align="center" rowspan="1" colspan="1">−0.16</td>
                          <td align="center" rowspan="1" colspan="1">0.87</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">TLFB average drinks</td>
                          <td align="center" rowspan="1" colspan="1">2, 102</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                          <td align="center" rowspan="1" colspan="1">21.53</td>
                          <td align="center" rowspan="1" colspan="1">&lt;0.001</td>
                          <td align="center" rowspan="1" colspan="1">2, 102</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                          <td align="center" rowspan="1" colspan="1">0.05</td>
                          <td align="center" rowspan="1" colspan="1">0.94</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">PT</td>
                          <td align="center" rowspan="1" colspan="1">−0.32 (0.11)</td>
                          <td align="center" rowspan="1" colspan="1">[−0.54, −0.10]</td>
                          <td align="center" rowspan="1" colspan="1">−2.91</td>
                          <td align="center" rowspan="1" colspan="1">0.004</td>
                          <td align="center" rowspan="1" colspan="1">−0.05 (0.16)</td>
                          <td align="center" rowspan="1" colspan="1">[−0.36, 0.26]</td>
                          <td align="center" rowspan="1" colspan="1">−0.32</td>
                          <td align="center" rowspan="1" colspan="1">0.74</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">FU</td>
                          <td align="center" rowspan="1" colspan="1">−0.46 (0.11)</td>
                          <td align="center" rowspan="1" colspan="1">[−0.69, −0.24]</td>
                          <td align="center" rowspan="1" colspan="1">−4.07</td>
                          <td align="center" rowspan="1" colspan="1">&lt;0.001</td>
                          <td align="center" rowspan="1" colspan="1">−0.03 (0.16)</td>
                          <td align="center" rowspan="1" colspan="1">[−0.34, 0.28]</td>
                          <td align="center" rowspan="1" colspan="1">−0.18</td>
                          <td align="center" rowspan="1" colspan="1">0.85</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Viral suppression (&lt;400)</td>
                          <td align="center" rowspan="1" colspan="1">2, 104</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                          <td align="center" rowspan="1" colspan="1">0.27</td>
                          <td align="center" rowspan="1" colspan="1">0.76</td>
                          <td align="center" rowspan="1" colspan="1">2, 104</td>
                          <td align="center" rowspan="1" colspan="1">–</td>
                          <td align="center" rowspan="1" colspan="1">0.72</td>
                          <td align="center" rowspan="1" colspan="1">0.49</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">PT</td>
                          <td align="center" rowspan="1" colspan="1">1.01 (0.77)</td>
                          <td align="center" rowspan="1" colspan="1">[−0.52, 2.53]</td>
                          <td align="center" rowspan="1" colspan="1">1.31</td>
                          <td align="center" rowspan="1" colspan="1">0.19</td>
                          <td align="center" rowspan="1" colspan="1">−1.31 (1.13)</td>
                          <td align="center" rowspan="1" colspan="1">[−3.56, 0.93]</td>
                          <td align="center" rowspan="1" colspan="1">−1.16</td>
                          <td align="center" rowspan="1" colspan="1">0.24</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">FU</td>
                          <td align="center" rowspan="1" colspan="1">0.81 (0.75)</td>
                          <td align="center" rowspan="1" colspan="1">[−0.69, 2.30]</td>
                          <td align="center" rowspan="1" colspan="1">1.07</td>
                          <td align="center" rowspan="1" colspan="1">0.28</td>
                          <td align="center" rowspan="1" colspan="1">−0.89 (1.10)</td>
                          <td align="center" rowspan="1" colspan="1">[−3.08, 1.29]</td>
                          <td align="center" rowspan="1" colspan="1">−0.81</td>
                          <td align="center" rowspan="1" colspan="1">0.41</td>
                        </tr>
                      </tbody>
                    </table>
                    <permissions>
                      <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                    </permissions>
                  </table-wrap>
                  <sec id="jia225720-sec-0018">
                    <title>ART adherence</title>
                    <p>There was a significant treatment‐by‐time interaction (estimate = −0.287 [95% CI = −0.507, −0.066]), such that ETAU’s pre‐post treatment change in days’ adherent was 28 percentage points lower than <italic>Khanya</italic>. Average adherence increased 6.4 percentage points in <italic>Khanya</italic>, whereas adherence declined by 22.3 percentage points in ETAU (see Figure <xref rid="jia225720-sup-0001" ref-type="supplementary-material">S1</xref>).</p>
                    <p>Although the study was focused on implementation, the fact that we saw large effects on behavioral adherence in this small sample is noteworthy. Improving ART adherence among individuals with AOD is a known challenge [<xref rid="jia225720-bib-0015" ref-type="ref">15</xref>]. Interventions to enhance adherence are critical for improving individual HIV outcomes and supporting treatment as prevention.</p>
                  </sec>
                  <sec id="jia225720-sec-0019">
                    <title>Alcohol and other drug use</title>
                    <sec id="jia225720-sec-0020">
                      <title>Biomarker</title>
                      <p>There was a significant main effect of time in the model predicting PEth (<italic>F</italic>(2,101) = 4.16, <italic>p</italic> = 0.01) and a non‐significant treatment‐by‐time interaction (<italic>F</italic>(2,101) = 0.97, <italic>p</italic> = 0.38), indicating both groups demonstrated reductions in PEth. In the model predicting negative urinalysis results for drug use or past three‐day alcohol use, the time (<italic>F</italic>(2,101) = 1.67, <italic>p</italic> = 0.19) and treatment‐by‐time interaction were not significant (<italic>F</italic>(2,101) = 0.59, <italic>p</italic> = 0.55).</p>
                    </sec>
                    <sec id="jia225720-sec-0021">
                      <title>WHO alcohol, smoking, and substance involvement screening test</title>
                      <p>There was a significant main effect of time in the model predicting the likelihood of moderate or high‐risk WHO‐ASSIST category (<italic>F</italic>(2,104) = 7.02, <italic>p</italic> = 0.001), but not the treatment‐by‐time interaction (<italic>F</italic>(2,104) = 0.10, <italic>p</italic> = 0.90). The probability of being in the high‐risk category reduced 30 percentage points at three months and 40 percentage points at six months.</p>
                    </sec>
                    <sec id="jia225720-sec-0022">
                      <title>Timeline follow‐back</title>
                      <p>There was a significant effect of time in the model predicting the average number of drinks consumed for <italic>Khanya</italic> (<italic>F</italic>(2,102) = 21.53, <italic>p</italic> &lt; 0.001). Participants in <italic>Khanya</italic> consumed on average 5.3 and 4.6 drinks at the subsequent time points, compared to 7.3 at baseline. However, the treatment‐by‐time interaction was not significant, indicating similar changes across groups over time. For the subsample who also used drugs, there was a marginally significant treatment‐by‐time interaction (<italic>F</italic>(2,31) = 3.28, <italic>p</italic> = 0.05); <italic>Khanya</italic> had a greater reduction in the number of drinks at six months compared to ETAU (see Figure <xref rid="jia225720-sup-0001" ref-type="supplementary-material">S2</xref>). Given the <italic>Khanya</italic> intervention did not require abstinence, it can be understood that individuals reduced amounts of alcohol consumed rather than abstinence.</p>
                    </sec>
                  </sec>
                  <sec id="jia225720-sec-0023">
                    <title>Viral load (exploratory)</title>
                    <p>There was no treatment effect on viral load (<italic>F</italic>(2,104) = 0.72, <italic>p</italic> = 0.49). However, we were not adequately powered in this pilot study to detect changes in viral load over a relatively short follow‐up period [<xref rid="jia225720-bib-0054" ref-type="ref">54</xref>, <xref rid="jia225720-bib-0055" ref-type="ref">55</xref>], especially since 63.9% of the sample was suppressed at baseline. However, there was a significant relationship between viral suppression and adherence; individuals with higher adherence at post‐treatment were more likely to be virally suppressed (<italic>t</italic> = 2.31; <italic>p</italic> = 0.02). Results are consistent with other behavioral intervention trials with a primary focus on ART adherence that did not demonstrate treatment effects on viral load [<xref rid="jia225720-bib-0056" ref-type="ref">56</xref>, <xref rid="jia225720-bib-0057" ref-type="ref">57</xref>, <xref rid="jia225720-bib-0058" ref-type="ref">58</xref>].</p>
                  </sec>
                </sec>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="jia225720-sec-0024">
              <label>4</label>
              <title>Conclusions</title>
              <p>This pilot trial provides initial evidence of the feasibility and acceptability of the peer‐delivered <italic>Khanya</italic> intervention for improving adherence alongside AOD in South African HIV care. Peers offer a potential solution to known implementation barriers of task‐sharing behavioral interventions with CHWs, including high caseloads and other clinical demands [<xref rid="jia225720-bib-0035" ref-type="ref">35</xref>, <xref rid="jia225720-bib-0059" ref-type="ref">59</xref>]. Peers bring with them lived experience, which can foster connection with patients and potentially reduce HIV and AOD stigma [<xref rid="jia225720-bib-0060" ref-type="ref">60</xref>, <xref rid="jia225720-bib-0061" ref-type="ref">61</xref>]. Initial results regarding the implementation success of <italic>Khanya</italic> and ART adherence improvements are promising. Results suggest that engagement in AOD treatment alone without integrated adherence support may not be sufficient to improve ART adherence; however, a larger trial is needed to evaluate longer term effectiveness outcomes, including viral suppression, and to consider a stepped care approach to efficiently allocate resources to support individuals most in need of intensive intervention.</p>
              <p>Strengths of this trial included a rigorous comparison condition, prioritization of individuals most in need of intervention – with both AOD and ART non‐adherence – use of a hybrid effectiveness‐implementation design, and high retention rates. Primary limitations relate to this being a pilot trial, including small sample size and relatively short follow‐up. As a pilot study, we were not powered to detect differences in viral load – an exploratory outcome. Furthermore, our urinalysis assessment of substance use included detection of alcohol use in the past three days; based on the alcohol use severity in this population and <italic>Khanya</italic>’s focus on reduction of use and harms rather than abstinence, we also had limited power to detect changes in urine‐verified abstinence. Finally, although real‐time electronic adherence monitoring is a strength, it has its limitations; Wisepill can act as an intervention in itself, and non‐use of Wisepill may be conflated with ART non‐adherence – although we limited our assessment to three months to minimize potential non‐use over time [<xref rid="jia225720-bib-0029" ref-type="ref">29</xref>]. Despite these limitations, this pilot study contributes new knowledge about incorporating peers as AOD interventionists within HIV care in SA. As SA Department of Health refines its strategy for integration of behavioral health services into primary care, findings may have important implications for the feasibility and acceptability of incorporating peers into task‐shared services for improving ART adherence among PLWH with AOD.</p>
            </sec>
            <sec id="jia225720-sec-0025">
              <title>Competing interests</title>
              <p>Dr. Safren receives royalties from Oxford University Press, Guilford Publications, and Springer/Humana Press for books related to cognitive behavioral therapy. All other authors declare no conflicts of interest.</p>
            </sec>
            <sec id="jia225720-sec-0026">
              <title>Authors’ contributions</title>
              <p>JFM conceptualized the idea and secured funding for the project with JAJ, BM and SAS. JM led all aspects of the study and wrote the first draft of the manuscript. JAJ, BM, COC and SAS provided guidance throughout the study and provided a critical review and edits of the manuscript. JMB conducted the analyses, oversaw data management and provided edits to the manuscript. LSA provided oversight of study operations, contributed to idea conceptualization and provided a critical review of the manuscript. KSR developed the protocol with JFM and SM and led all aspects of study start up, operations, data oversight and regulatory compliance, along with SM, and contributed to manuscript writing. ALR oversaw study operations, procedures for biomarker specimen testing and analysis along with SM, and contributed to manuscript writing. All authors approve of the final manuscript to be submitted for publication.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material content-type="local-data" id="jia225720-sup-0001">
                <caption>
                  <p><bold>Figure S1</bold>. Model‐implied Wisepill adherence at baseline and post‐treatment (three‐months) for ETAU and Khanya intervention groups</p>
                  <p><bold>Figure S2</bold>. Model‐implied alcohol use quantity at baseline, post‐treatment, and follow‐up time points for ETAU and intervention groups among the subsample who used both drugs and alcohol (<italic>n</italic> = 21)</p>
                </caption>
                <media xlink:href="JIA2-24-e25720-s001.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="jia225720-sup-0002">
                <caption>
                  <p><bold>Table S1</bold>. Linear model predicting wisepill adherence</p>
                  <p><bold>Table S2</bold>. Linear model predicting continuous PEth and categorical model predicting dichotomous urine</p>
                  <p><bold>Table S3</bold>. Cumulative logit model predicting moderate and high risk categories of WHO‐ASSIST</p>
                  <p><bold>Table S4</bold>. Count model predicting average number of drinks consumed on days drinking on the timeline followback</p>
                  <p><bold>Table S5</bold>. Linear model predicting percentage days used any substance on the timeline followback</p>
                  <p><bold>Table S6</bold>. Categorical model predicting binary viral load suppression</p>
                </caption>
                <media xlink:href="JIA2-24-e25720-s002.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack id="jia225720-sec-0027">
              <title>Acknowledgements</title>
              <p>We acknowledge the rest of the Project Khanya team, including but not limited to Nonceba Ciya, Neliswa Kotelo, Sibabalwe Ndamase, Jasper Lee, Emily Satinsky, Hannah Tralka, Christine Wan, and Morgan Anvari and additional mentorship and guidance from Dr. Ashraf Kagee, Warren Burnhams, Dr. David Henderson, Dr. Gregory Fricchione and Dr. Christina Borba. We also acknowledge the City of Cape Town Department of Health for their support and for granting us access to their clinics. We thank the staff, patients and Community Advisory Boards at the Town Two clinic for their time, effort, and support. We would especially like to thank the study participants for their time, input, and contributions to this study.</p>
              <sec id="jia225720-sec-0028">
                <title>Funding</title>
                <p>This study was funded by the National Institute of Drug Abuse (NIDA): K23DA041901 (PI: Magidson) and K23DA041901‐S1 (Biomarker supplement; PI: Magidson). Dr. Safren’s time was funded by 9K24DA040489, 1P30MH116867 and R01MH103770. Drs. Joska, Andersen and O’Cleirigh were also funded by R01MH103770. Ms. Majokweni was supported by both K23DA041901 and R01MH103770. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, National Institute of Drug Abuse or National Institute of Mental Health.</p>
              </sec>
            </ack>
            <ref-list content-type="cited-references" id="jia225720-bibl-0001">
              <title>References</title>
              <ref id="jia225720-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="miscellaneous" id="jia225720-cit-0001"><article-title>Statistics South Africa. 2020 Mid‐year population estimates</article-title> [Internet]. <year>2020</year>. [cited 2020 Aug 24]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.statssa.gov.za/?p=13453">http://www.statssa.gov.za/?p=13453</ext-link>
</mixed-citation>
              </ref>
              <ref id="jia225720-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0002"><string-name><surname>Moorhouse</surname><given-names>M</given-names></string-name>, <string-name><surname>Maartens</surname><given-names>G</given-names></string-name>, <string-name><surname>Venter</surname><given-names>WDF</given-names></string-name>, <string-name><surname>Moosa</surname><given-names>M‐Y</given-names></string-name>, <string-name><surname>Steegen</surname><given-names>K</given-names></string-name>, <string-name><surname>Jamaloodien</surname><given-names>K</given-names></string-name>, et al. <article-title>Third‐line antiretroviral therapy program in the south african public sector: cohort description and virological outcomes</article-title>. <source xml:lang="en">JAIDS J Acquir Immune Defic Syndr</source> [Internet]. <year>2019</year>;<volume>80</volume>(<issue>1</issue>): [cited 2020 Aug 24]. Available from: <ext-link ext-link-type="uri" xlink:href="https://journals.lww.com/jaids/Fulltext/2019/01010/Third_Line_Antiretroviral_Therapy_Program_in_the.13.aspx">https://journals.lww.com/jaids/Fulltext/2019/01010/Third_Line_Antiretroviral_Therapy_Program_in_the.13.aspx</ext-link>
</mixed-citation>
              </ref>
              <ref id="jia225720-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0003"><string-name><surname>Nachega</surname><given-names>JB</given-names></string-name>, <string-name><surname>Marconi</surname><given-names>VC</given-names></string-name>, <string-name><surname>van Zyl</surname><given-names>GU</given-names></string-name>, <string-name><surname>Gardner</surname><given-names>EM</given-names></string-name>, <string-name><surname>Preiser</surname><given-names>W</given-names></string-name>, <string-name><surname>Hong</surname><given-names>SY</given-names></string-name>, et al. <article-title>HIV treatment adherence, drug resistance, virologic failure: evolving concepts</article-title>. <source xml:lang="en">Infect Disord Drug Targets</source>. <year>2011</year>;<volume>11</volume>(<issue>2</issue>):<fpage>167</fpage>–<lpage>74</lpage>.<pub-id pub-id-type="pmid">21406048</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0004">
                <label>4</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0004"><string-name><surname>Marconi</surname><given-names>VC</given-names></string-name>, <string-name><surname>Sunpath</surname><given-names>H</given-names></string-name>, <string-name><surname>Lu</surname><given-names>Z</given-names></string-name>, <string-name><surname>Gordon</surname><given-names>M</given-names></string-name>, <string-name><surname>Koranteng‐Apeagyei</surname><given-names>K</given-names></string-name>, <string-name><surname>Hampton</surname><given-names>J</given-names></string-name>, et al. <article-title>Prevalence of HIV‐1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa</article-title>. <source xml:lang="en">Clin Infect Dis</source>. <year>2008</year>;<volume>46</volume>(<issue>10</issue>):<fpage>1589</fpage>–<lpage>97</lpage>.<pub-id pub-id-type="pmid">18419495</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0005"><string-name><surname>Viet Cuong</surname><given-names>P</given-names></string-name>, <string-name><surname>Casswell</surname><given-names>S</given-names></string-name>, <string-name><surname>Parker</surname><given-names>K</given-names></string-name>, <string-name><surname>Callinan</surname><given-names>S</given-names></string-name>, <string-name><surname>Chaiyasong</surname><given-names>S</given-names></string-name>, <string-name><surname>Kazantseva</surname><given-names>E</given-names></string-name>, et al. <article-title>Cross‐country comparison of proportion of alcohol consumed in harmful drinking occasions using the International Alcohol Control Study</article-title>. <source xml:lang="en">Drug Alcohol Rev</source>. <year>2018</year>;<volume>37</volume><issue>Suppl 2</issue>:<fpage>S45</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="pmid">29441632</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0006"><string-name><surname>Scheibe</surname><given-names>AP</given-names></string-name>, <string-name><surname>Gloeck</surname><given-names>NR</given-names></string-name>, <string-name><surname>Shelly</surname><given-names>S</given-names></string-name>, <string-name><surname>Marcus</surname><given-names>TS</given-names></string-name>, <string-name><surname>Hugo</surname><given-names>J</given-names></string-name>. <article-title>The prevalence and characteristics of moderate‐ to high‐risk regulated and unregulated substance use among patients admitted to four public hospitals in Tshwane, South Africa</article-title>. <source xml:lang="en">S Afr Med J</source>. <year>2019</year>;<volume>109</volume>(<issue>12</issue>) [Internet]. [cited 2020 Aug 24]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.samj.org.za/index.php/samj/article/view/12777">http://www.samj.org.za/index.php/samj/article/view/12777</ext-link></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0007"><string-name><surname>Parry</surname><given-names>CD</given-names></string-name>, <string-name><surname>Londani</surname><given-names>M</given-names></string-name>, <string-name><surname>Shuper</surname><given-names>PA</given-names></string-name>, <string-name><surname>Myers</surname><given-names>B</given-names></string-name>, <string-name><surname>Kekwaletswe</surname><given-names>CT</given-names></string-name>, <string-name><surname>Nkosi</surname><given-names>S</given-names></string-name>, et al. <article-title>Characteristics and drinking behaviour of patients on antiretroviral therapy who drink and attend HIV clinics in Tshwane, South Africa: implications for intervention</article-title>. <source xml:lang="en">S Afr Med J</source>. <year>2019</year>;<volume>109</volume>(<issue>10</issue>):<fpage>784</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="pmid">31635577</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0008"><string-name><surname>Myers</surname><given-names>B.</given-names></string-name>, <string-name><surname>Lombard</surname><given-names>C.</given-names></string-name>, <string-name><surname>Joska</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Abdullah</surname><given-names>F.</given-names></string-name>, <string-name><surname>Naledi</surname><given-names>T.</given-names></string-name>, <string-name><surname>Lund</surname><given-names>C.</given-names></string-name>, et al. <article-title>Associations Between Patterns of Alcohol Use and Viral Load Suppression Amongst Women Living with HIV in South Africa</article-title>. <source xml:lang="en">AIDS Behav</source>. (<year>2021</year>). <pub-id pub-id-type="doi">10.1007/s10461-021-03263-3</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0009"><string-name><surname>Cook</surname><given-names>RL</given-names></string-name>, <string-name><surname>Sereika</surname><given-names>SM</given-names></string-name>, <string-name><surname>Hunt</surname><given-names>SC</given-names></string-name>, <string-name><surname>Woodward</surname><given-names>WC</given-names></string-name>, <string-name><surname>Erlen</surname><given-names>JA</given-names></string-name>, <string-name><surname>Conigliaro</surname><given-names>J</given-names></string-name>. <article-title>Problem drinking and medication adherence among persons with HIV infection</article-title>. <source xml:lang="en">J Gen Intern Med</source>. <year>2001</year>;<volume>16</volume>(<issue>2</issue>):<fpage>83</fpage>–<lpage>88</lpage>.<pub-id pub-id-type="pmid">11251758</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0010">
                <label>10</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0010"><string-name><surname>Kader</surname><given-names>R</given-names></string-name>, <string-name><surname>Seedat</surname><given-names>S</given-names></string-name>, <string-name><surname>Govender</surname><given-names>R</given-names></string-name>, <string-name><surname>Koch</surname><given-names>JR</given-names></string-name>, <string-name><surname>Parry</surname><given-names>CD</given-names></string-name>. <article-title>Hazardous and harmful use of alcohol and/or other drugs and health status among South African patients attending HIV clinics</article-title>. <source xml:lang="en">AIDS Behav</source>. <year>2014</year>;<volume>18</volume>(<issue>3</issue>):<fpage>525</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="pmid">23921585</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0011"><string-name><surname>Kalichman</surname><given-names>SC</given-names></string-name>, <string-name><surname>Simbayi</surname><given-names>LC</given-names></string-name>, <string-name><surname>Kaufman</surname><given-names>M</given-names></string-name>, <string-name><surname>Cain</surname><given-names>D</given-names></string-name>, <string-name><surname>Jooste</surname><given-names>S</given-names></string-name>. <article-title>Alcohol use and sexual risks for HIV/AIDS in sub‐Saharan Africa: systematic review of empirical findings</article-title>. <source xml:lang="en">Prev Sci</source>. <year>2007</year>;<volume>8</volume>(<issue>2</issue>):<fpage>141</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">17265194</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0012"><string-name><surname>Patterson</surname><given-names>TL</given-names></string-name>, <string-name><surname>Semple</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Zians</surname><given-names>JK</given-names></string-name>, <string-name><surname>Strathdee</surname><given-names>SA</given-names></string-name>. <article-title>Methamphetamine‐using HIV‐positive men who have sex with men: correlates of polydrug use</article-title>. <source xml:lang="en">J Urban Health</source>. <year>2005</year>;<volume>82</volume>(<issue>1</issue>):<fpage>i120</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="pmid">15738313</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0013">
                <label>13</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0013"><string-name><surname>Kekwaletswe</surname><given-names>CT</given-names></string-name>, <string-name><surname>Jordaan</surname><given-names>E</given-names></string-name>, <string-name><surname>Nkosi</surname><given-names>S</given-names></string-name>, <string-name><surname>Morojele</surname><given-names>NK</given-names></string-name>. <article-title>Social support and the mediating roles of alcohol Use and adherence self‐efficacy on Antiretroviral Therapy (ART) adherence among ART recipients in Gauteng, South Africa</article-title>. <source xml:lang="en">AIDS Behav</source>. <year>2017</year>;<volume>21</volume>(<issue>7</issue>):<fpage>1846</fpage>–<lpage>56</lpage>.<pub-id pub-id-type="pmid">27837424</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0014">
                <label>14</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0014"><string-name><surname>Velloza</surname><given-names>J</given-names></string-name>, <string-name><surname>Kemp</surname><given-names>CG</given-names></string-name>, <string-name><surname>Aunon</surname><given-names>FM</given-names></string-name>, <string-name><surname>Ramaiya</surname><given-names>MK</given-names></string-name>, <string-name><surname>Creegan</surname><given-names>E</given-names></string-name>, <string-name><surname>Simoni</surname><given-names>JM</given-names></string-name>. <article-title>Alcohol use and antiretroviral therapy non‐adherence among adults living with HIV/AIDS in sub‐Saharan Africa: a systematic review and meta‐analysis</article-title>. <source xml:lang="en">AIDS Behav</source>. <year>2020</year>;<volume>24</volume>(<issue>6</issue>):<fpage>1727</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">31673913</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0015">
                <label>15</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0015"><string-name><surname>Williams</surname><given-names>EC</given-names></string-name>, <string-name><surname>McGinnis</surname><given-names>KA</given-names></string-name>, <string-name><surname>Rubinsky</surname><given-names>AD</given-names></string-name>, <string-name><surname>Matson</surname><given-names>TE</given-names></string-name>, <string-name><surname>Bobb</surname><given-names>JF</given-names></string-name>, <string-name><surname>Lapham</surname><given-names>GT</given-names></string-name>, et al. <article-title>Alcohol use and antiretroviral adherence among patients living with HIV: is change in alcohol use associated with change in adherence?</article-title><source xml:lang="en">AIDS Behav</source>. <year>2021</year>;<volume>25</volume>(<issue>1</issue>):<fpage>203</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">32617778</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0016">
                <label>16</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0016"><string-name><surname>Parsons</surname><given-names>JT</given-names></string-name>, <string-name><surname>Golub</surname><given-names>SA</given-names></string-name>, <string-name><surname>Rosof</surname><given-names>E</given-names></string-name>, <string-name><surname>Holder</surname><given-names>C</given-names></string-name>. <article-title>Motivational interviewing and cognitive‐behavioral intervention to improve HIV medication adherence among hazardous drinkers</article-title>. <source xml:lang="en">J Acquir Immune Defic Syndr</source>. <year>2007</year>;<volume>46</volume>(<issue>4</issue>):<fpage>443</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">18077833</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0017">
                <label>17</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0017"><string-name><surname>Parsons</surname><given-names>JT</given-names></string-name>, <string-name><surname>John</surname><given-names>SA</given-names></string-name>, <string-name><surname>Millar</surname><given-names>BM</given-names></string-name>, <string-name><surname>Starks</surname><given-names>TJ</given-names></string-name>. <article-title>Testing the efficacy of combined motivational interviewing and cognitive behavioral skills training to reduce methamphetamine use and improve HIV medication adherence among HIV‐positive gay and bisexual Men</article-title>. <source xml:lang="en">AIDS Behav</source>. <year>2018</year>;<volume>22</volume>(<issue>8</issue>):<fpage>2674</fpage>–<lpage>86</lpage>.<pub-id pub-id-type="pmid">29536284</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0018">
                <label>18</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0018"><string-name><surname>Haldane</surname><given-names>V</given-names></string-name>, <string-name><surname>Cervero‐Liceras</surname><given-names>F</given-names></string-name>, <string-name><surname>Chuah</surname><given-names>FL</given-names></string-name>, <string-name><surname>Ong</surname><given-names>SE</given-names></string-name>, <string-name><surname>Murphy</surname><given-names>G</given-names></string-name>, <string-name><surname>Sigfrid</surname><given-names>L</given-names></string-name>, et al. <article-title>Integrating HIV and substance use services: a systematic review</article-title>. <source xml:lang="en">J Int AIDS Soc</source> [Internet]. <year>2017</year>;<volume>20</volume>(<issue>1</issue>). 21585 [cited 2020 Aug 24]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515016/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515016/</ext-link>
</mixed-citation>
              </ref>
              <ref id="jia225720-bib-0019">
                <label>19</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0019"><string-name><surname>Jenkins</surname><given-names>RA</given-names></string-name>. <article-title>Getting to zero: we can’t do it without addressing substance use</article-title>. <source xml:lang="en">AIDS Educ Prev</source>. <year>2018</year>;<volume>30</volume>(<issue>3</issue>):<fpage>225</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="pmid">29969312</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0020">
                <label>20</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0020"><string-name><surname>Dale</surname><given-names>SK</given-names></string-name>, <string-name><surname>Traeger</surname><given-names>L</given-names></string-name>, <string-name><surname>O’Cleirigh</surname><given-names>C</given-names></string-name>, <string-name><surname>Bedoya</surname><given-names>CA</given-names></string-name>, <string-name><surname>Pinkston</surname><given-names>M</given-names></string-name>, <string-name><surname>Wilner</surname><given-names>JG</given-names></string-name>, et al. <article-title>Baseline substance use interferes with maintenance of HIV medication adherence skills</article-title>. <source xml:lang="en">AIDS Patient Care and STDs</source>. <year>2016</year>;<volume>30</volume>(<issue>5</issue>):<fpage>215</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">27158849</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0021">
                <label>21</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0021"><string-name><surname>Myers</surname><given-names>B</given-names></string-name>, <string-name><surname>Sorsdahl</surname><given-names>K</given-names></string-name>, <string-name><surname>Morojele</surname><given-names>NK</given-names></string-name>, <string-name><surname>Kekwaletswe</surname><given-names>C</given-names></string-name>, <string-name><surname>Shuper</surname><given-names>PA</given-names></string-name>, <string-name><surname>Parry</surname><given-names>CDH</given-names></string-name>. <article-title>“In this thing I have everything I need”: perceived acceptability of a brief alcohol‐focused intervention for people living with HIV</article-title>. <source xml:lang="en">AIDS Care</source>. <year>2017</year>;<volume>29</volume>(<issue>2</issue>):<fpage>209</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">27435957</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0022">
                <label>22</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0022"><string-name><surname>Kekwaletswe</surname><given-names>CT</given-names></string-name>, <string-name><surname>Morojele</surname><given-names>NK</given-names></string-name>. <article-title>Alcohol use, antiretroviral therapy adherence, and preferences regarding an alcohol‐focused adherence intervention in patients with human immunodeficiency virus</article-title>. <source xml:lang="en">Patient Prefer Adherence</source>. <year>2014</year>;<volume>31</volume>(<issue>8</issue>):<fpage>401</fpage>–<lpage>13</lpage>.</mixed-citation>
              </ref>
              <ref id="jia225720-bib-0023">
                <label>23</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0023"><string-name><surname>Myers</surname><given-names>B</given-names></string-name>, <string-name><surname>Parry</surname><given-names>CDH</given-names></string-name>, <string-name><surname>Morojele</surname><given-names>NK</given-names></string-name>, <string-name><surname>Nkosi</surname><given-names>S</given-names></string-name>, <string-name><surname>Shuper</surname><given-names>PA</given-names></string-name>, <string-name><surname>Kekwaletswe</surname><given-names>CT</given-names></string-name>, et al. <article-title>“Moving forward with life”: acceptability of a brief alcohol reduction intervention for people receiving antiretroviral therapy in South Africa</article-title>. <source xml:lang="en">Int J Environ Res Public Health</source>. <year>2020</year>;<volume>17</volume>:<elocation-id>5706</elocation-id>.</mixed-citation>
              </ref>
              <ref id="jia225720-bib-0024">
                <label>24</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0024"><string-name><surname>Curran</surname><given-names>GM</given-names></string-name>, <string-name><surname>Bauer</surname><given-names>M</given-names></string-name>, <string-name><surname>Mittman</surname><given-names>B</given-names></string-name>, <string-name><surname>Pyne</surname><given-names>JM</given-names></string-name>, <string-name><surname>Stetler</surname><given-names>C</given-names></string-name>. <article-title>Effectiveness‐implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact</article-title>. <source xml:lang="en">Med Care</source>. <year>2012</year>;<volume>50</volume>(<issue>3</issue>):<fpage>217</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="pmid">22310560</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0025">
                <label>25</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0025"><string-name><surname>Gouse</surname><given-names>H</given-names></string-name>, <string-name><surname>Magidson</surname><given-names>JF</given-names></string-name>, <string-name><surname>Burnhams</surname><given-names>W</given-names></string-name>, <string-name><surname>Remmert</surname><given-names>JE</given-names></string-name>, <string-name><surname>Myers</surname><given-names>B</given-names></string-name>, <string-name><surname>Joska</surname><given-names>JA</given-names></string-name>, et al. <article-title>Implementation of cognitive‐behavioral substance abuse treatment in sub‐Saharan Africa: treatment engagement and abstinence at treatment exit</article-title>. <source xml:lang="en">PLoS One</source> [Internet]. <year>2016</year>; Jan 27 [cited 2019 Nov 22];<volume>11</volume>(<issue>1</issue>). Available from: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729488/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729488/</ext-link>
</mixed-citation>
              </ref>
              <ref id="jia225720-bib-0026">
                <label>26</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0026"><string-name><surname>Magidson</surname><given-names>JF</given-names></string-name>, <string-name><surname>Gouse</surname><given-names>H</given-names></string-name>, <string-name><surname>Burnhams</surname><given-names>W</given-names></string-name>, <string-name><surname>Wu</surname><given-names>CYY</given-names></string-name>, <string-name><surname>Myers</surname><given-names>B</given-names></string-name>, <string-name><surname>Joska</surname><given-names>JA</given-names></string-name>, et al. <article-title>Beyond methamphetamine: documenting the implementation of the Matrix model of substance use treatment for opioid users in a South African setting</article-title>. <source xml:lang="en">Addict Behav</source>. <year>2017</year>;<volume>66</volume>:<fpage>132</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">27940387</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0027">
                <label>27</label>
                <mixed-citation publication-type="miscellaneous" id="jia225720-cit-0027"><collab collab-type="authors">Western Cape Provincial AIDS Council</collab>
. <article-title>Annual Progress Report 2014/15</article-title> [Internet]. South Africa: Western Cape Government; <year>2016</year> Mar. (Provincial Strategic Plan 2012‐2016). [cited 2020 Aug 24]. Available from: <ext-link ext-link-type="uri" xlink:href="http://sanac.org.za/wp-content/uploads/2016/04/WC_PSP-ANNUAL-PROGRESS-REPORT-Final.pdf">http://sanac.org.za/wp‐content/uploads/2016/04/WC_PSP‐ANNUAL‐PROGRESS‐REPORT‐Final.pdf</ext-link>
</mixed-citation>
              </ref>
              <ref id="jia225720-bib-0028">
                <label>28</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0028"><collab collab-type="authors">WHO Assist Working Group</collab>
. <article-title>The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility</article-title>. <source xml:lang="en">Addiction</source>. <year>2002</year>;<volume>97</volume>(<issue>9</issue>):<fpage>1183</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="pmid">12199834</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0029">
                <label>29</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0029"><string-name><surname>Haberer</surname><given-names>JE</given-names></string-name>, <string-name><surname>Kahane</surname><given-names>J</given-names></string-name>, <string-name><surname>Kigozi</surname><given-names>I</given-names></string-name>, <string-name><surname>Emenyonu</surname><given-names>N</given-names></string-name>, <string-name><surname>Hunt</surname><given-names>P</given-names></string-name>, <string-name><surname>Martin</surname><given-names>J</given-names></string-name>, et al. <article-title>Real‐time adherence monitoring for HIV antiretroviral therapy</article-title>. <source xml:lang="en">AIDS Behav</source>. <year>2010</year>;<volume>14</volume>(<issue>6</issue>):<fpage>1340</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">20809380</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0030">
                <label>30</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0030"><string-name><surname>Magidson</surname><given-names>JF</given-names></string-name>, <string-name><surname>Joska</surname><given-names>JA</given-names></string-name>, <string-name><surname>Myers</surname><given-names>B</given-names></string-name>, <string-name><surname>Belus</surname><given-names>JM</given-names></string-name>, <string-name><surname>Regenauer</surname><given-names>KS</given-names></string-name>, <string-name><surname>Andersen</surname><given-names>LS</given-names></string-name>, et al. <article-title>Project Khanya: a randomized, hybrid effectiveness‐implementation trial of a peer‐delivered behavioral intervention for ART adherence and substance use in Cape Town, South Africa</article-title>. <source xml:lang="en">Implement Sci Commun</source>. <year>2020</year>;<volume>1</volume>(<issue>23</issue>).</mixed-citation>
              </ref>
              <ref id="jia225720-bib-0031">
                <label>31</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0031"><string-name><surname>Safren</surname><given-names>S</given-names></string-name>, <string-name><surname>Otto</surname><given-names>M</given-names></string-name>, <string-name><surname>Worth</surname><given-names>J</given-names></string-name>. <article-title>Life‐steps: applying cognitive behavioral therapy to HIV medication adherence</article-title>. <source xml:lang="en">Sci Direct Cognit Behav Pract</source>. <year>1999</year>;<volume>6</volume>(<issue>4</issue>):<fpage>332</fpage>–<lpage>41</lpage>.</mixed-citation>
              </ref>
              <ref id="jia225720-bib-0032">
                <label>32</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0032"><string-name><surname>Daughters</surname><given-names>SB</given-names></string-name>, <string-name><surname>Magidson</surname><given-names>JF</given-names></string-name>, <string-name><surname>Anand</surname><given-names>D</given-names></string-name>, <string-name><surname>Seitz‐Brown</surname><given-names>CJ</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Y</given-names></string-name>, <string-name><surname>Baker</surname><given-names>S</given-names></string-name>. <article-title>The effect of a behavioral activation treatment for substance use on post‐treatment abstinence: a randomized controlled trial</article-title>. <source xml:lang="en">Addiction</source>. <year>2018</year>;<volume>113</volume>(<issue>3</issue>):<fpage>535</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="pmid">28963853</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0033">
                <label>33</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0033"><string-name><surname>Bowen</surname><given-names>S</given-names></string-name>, <string-name><surname>Witkiewitz</surname><given-names>K</given-names></string-name>, <string-name><surname>Clifasefi</surname><given-names>SL</given-names></string-name>, <string-name><surname>Grow</surname><given-names>J</given-names></string-name>, <string-name><surname>Chawla</surname><given-names>N</given-names></string-name>, <string-name><surname>Hsu</surname><given-names>SH</given-names></string-name>, et al. <article-title>Relative efficacy of mindfulness‐based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial</article-title>. <source xml:lang="en">JAMA Psychiatry</source>. <year>2014</year>;<volume>71</volume>(<issue>5</issue>):<fpage>547</fpage>–<lpage>56</lpage>.<pub-id pub-id-type="pmid">24647726</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0034">
                <label>34</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0034"><string-name><surname>Magill</surname><given-names>M</given-names></string-name>, <string-name><surname>Apodaca</surname><given-names>TR</given-names></string-name>, <string-name><surname>Borsari</surname><given-names>B</given-names></string-name>, <string-name><surname>Gaume</surname><given-names>J</given-names></string-name>, <string-name><surname>Hoadley</surname><given-names>A</given-names></string-name>, <string-name><surname>Gordon</surname><given-names>REF</given-names></string-name>, et al. <article-title>A meta‐analysis of motivational interviewing process: Technical, relational, and conditional process models of change</article-title>. <source xml:lang="en">J Consult Clin Psychol</source>. <year>2018</year>;<volume>86</volume>(<issue>2</issue>):<fpage>140</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="pmid">29265832</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0035">
                <label>35</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0035"><string-name><surname>Magidson</surname><given-names>JF</given-names></string-name>, <string-name><surname>Joska</surname><given-names>JA</given-names></string-name>, <string-name><surname>Regenauer</surname><given-names>KS</given-names></string-name>, <string-name><surname>Satinsky</surname><given-names>E</given-names></string-name>, <string-name><surname>Andersen</surname><given-names>LS</given-names></string-name>, <string-name><surname>Seitz‐Brown</surname><given-names>CJ</given-names></string-name>, et al. <article-title>“Someone who is in this thing that I am suffering from”: the role of peers and other facilitators for task sharing substance use treatment in South African HIV care</article-title>. <source xml:lang="en">Int J Drug Policy</source>. <year>2019</year>;<volume>70</volume>:<fpage>61</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">31082664</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0036">
                <label>36</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0036"><string-name><surname>Magidson</surname><given-names>JF</given-names></string-name>, <string-name><surname>Andersen</surname><given-names>LS</given-names></string-name>, <string-name><surname>Satinsky</surname><given-names>EN</given-names></string-name>, <string-name><surname>Myers</surname><given-names>B</given-names></string-name>, <string-name><surname>Kagee</surname><given-names>A</given-names></string-name>, <string-name><surname>Anvari</surname><given-names>M</given-names></string-name>, et al. <article-title>“Too much boredom isn’t a good thing”: adapting behavioral activation for substance use in a resource‐limited South African HIV care setting</article-title>. <source xml:lang="en">Psychotherapy</source>. <year>2020</year>;<volume>57</volume>(<issue>1</issue>):<fpage>107</fpage>–<lpage>18</lpage>.<pub-id pub-id-type="pmid">31670529</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0037">
                <label>37</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0037"><string-name><surname>Belus</surname><given-names>JM</given-names></string-name>, <string-name><surname>Rose</surname><given-names>AL</given-names></string-name>, <string-name><surname>Andersen</surname><given-names>LS</given-names></string-name>, <string-name><surname>Ciya</surname><given-names>N</given-names></string-name>, <string-name><surname>Joska</surname><given-names>JA</given-names></string-name>, <string-name><surname>Myers</surname><given-names>B</given-names></string-name>, et al. <article-title>Adapting a behavioral intervention for alcohol use and HIV medication adherence for lay counselor delivery in Cape Town, South Africa: A case series</article-title>. <source xml:lang="en">Cognitive and Behavioral Practice</source>. <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="jia225720-bib-0038">
                <label>38</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0038"><string-name><surname>Rawson</surname><given-names>RA</given-names></string-name>, <string-name><surname>Shoptaw</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Obert</surname><given-names>JL</given-names></string-name>, <string-name><surname>McCann</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Hasson</surname><given-names>AL</given-names></string-name>, <string-name><surname>Marinelli‐Casey</surname><given-names>PJ</given-names></string-name>, et al. <article-title>An intensive outpatient approach for cocaine abuse treatment: the Matrix model</article-title>. <source xml:lang="en">J Subst Abuse Treat</source>. <year>1995</year>;<volume>12</volume>(<issue>2</issue>):<fpage>117</fpage>–<lpage>27</lpage>.<pub-id pub-id-type="pmid">7623389</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0039">
                <label>39</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0039"><string-name><surname>Obert</surname><given-names>JL</given-names></string-name>, <string-name><surname>McCann</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Marinelli‐Casey</surname><given-names>P</given-names></string-name>, <string-name><surname>Weiner</surname><given-names>A</given-names></string-name>, <string-name><surname>Minsky</surname><given-names>S</given-names></string-name>, <string-name><surname>Brethen</surname><given-names>P</given-names></string-name>, et al. <article-title>The matrix model of outpatient stimulant abuse treatment: history and description</article-title>. <source xml:lang="en">J Psychoactive Drugs</source>. <year>2000</year>;<volume>32</volume>(<issue>2</issue>):<fpage>157</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="pmid">10908003</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0040">
                <label>40</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0040"><string-name><surname>Proctor</surname><given-names>E</given-names></string-name>, <string-name><surname>Silmere</surname><given-names>H</given-names></string-name>, <string-name><surname>Raghavan</surname><given-names>R</given-names></string-name>, <string-name><surname>Hovmand</surname><given-names>P</given-names></string-name>, <string-name><surname>Aarons</surname><given-names>G</given-names></string-name>, <string-name><surname>Bunger</surname><given-names>A</given-names></string-name>, et al. <article-title>Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda</article-title>. <source xml:lang="en">Adminis Policy Mental Health Mental Health Serv Res</source>. <year>2011</year>;<volume>38</volume>(<issue>2</issue>):<fpage>65</fpage>–<lpage>76</lpage>.</mixed-citation>
              </ref>
              <ref id="jia225720-bib-0041">
                <label>41</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0041"><string-name><surname>Haroz</surname><given-names>EE</given-names></string-name>, <string-name><surname>Bolton</surname><given-names>P</given-names></string-name>, <string-name><surname>Nguyen</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Lee</surname><given-names>C</given-names></string-name>, <string-name><surname>Bogdanov</surname><given-names>S</given-names></string-name>, <string-name><surname>Bass</surname><given-names>J</given-names></string-name>, et al. <article-title>Measuring implementation in global mental health: validation of a pragmatic implementation science measure in eastern Ukraine using an experimental vignette design</article-title>. <source xml:lang="en">BMC Health Serv Res</source>. <year>2019</year>;<volume>19</volume>(<issue>1</issue>):<fpage>262</fpage>.<pub-id pub-id-type="pmid">31036002</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0042">
                <label>42</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0042"><string-name><surname>Dorsey</surname><given-names>S</given-names></string-name>, <string-name><surname>Lyon</surname><given-names>AR</given-names></string-name>, <string-name><surname>Pullmann</surname><given-names>MD</given-names></string-name>, <string-name><surname>Jungbluth</surname><given-names>N</given-names></string-name>, <string-name><surname>Berliner</surname><given-names>L</given-names></string-name>, <string-name><surname>Beidas</surname><given-names>R</given-names></string-name>. <article-title>Behavioral rehearsal for analogue fidelity: feasibility in a state‐funded children's mental health initiative</article-title>. <source xml:lang="en">Adm Policy Ment Health</source>. <year>2017</year>;<volume>44</volume>(<issue>3</issue>):<fpage>395</fpage>–<lpage>404</lpage>.<pub-id pub-id-type="pmid">26966103</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0043">
                <label>43</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0043"><string-name><surname>Kohrt</surname><given-names>BA</given-names></string-name>, <string-name><surname>Jordans</surname><given-names>MJD</given-names></string-name>, <string-name><surname>Rai</surname><given-names>S</given-names></string-name>, <string-name><surname>Shrestha</surname><given-names>P</given-names></string-name>, <string-name><surname>Luitel</surname><given-names>NP</given-names></string-name>, <string-name><surname>Ramaiya</surname><given-names>MK</given-names></string-name>, et al. <article-title>Therapist competence in global mental health: development of the ENhancing Assessment of Common Therapeutic factors (ENACT) rating scale</article-title>. <source xml:lang="en">Behav Res Ther</source>. <year>2015</year>;<volume>1</volume>(<issue>69</issue>):<fpage>11</fpage>–<lpage>21</lpage>.</mixed-citation>
              </ref>
              <ref id="jia225720-bib-0044">
                <label>44</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0044"><string-name><surname>Magidson</surname><given-names>JF</given-names></string-name>, <string-name><surname>Fatch</surname><given-names>R</given-names></string-name>, <string-name><surname>Orrell</surname><given-names>C</given-names></string-name>, <string-name><surname>Amanyire</surname><given-names>G</given-names></string-name>, <string-name><surname>Haberer</surname><given-names>JE</given-names></string-name>, <string-name><surname>Hahn</surname><given-names>JA</given-names></string-name>, et al. <article-title>Biomarker‐measured unhealthy alcohol use in relation to CD4 count among individuals starting ART in Sub‐Saharan Africa</article-title>. <source xml:lang="en">AIDS Behav</source>. <year>2019</year>;<volume>23</volume>(<issue>6</issue>):<fpage>1656</fpage>–<lpage>67</lpage>.<pub-id pub-id-type="pmid">30560484</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0045">
                <label>45</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0045"><string-name><surname>Vinikoor</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Zyambo</surname><given-names>Z</given-names></string-name>, <string-name><surname>Muyoyeta</surname><given-names>M</given-names></string-name>, <string-name><surname>Chander</surname><given-names>G</given-names></string-name>, <string-name><surname>Saag</surname><given-names>MS</given-names></string-name>, <string-name><surname>Cropsey</surname><given-names>K</given-names></string-name>. <article-title>Point‐of‐care urine ethyl glucuronide testing to detect alcohol use among HIV‐hepatitis B virus coinfected adults in Zambia</article-title>. <source xml:lang="en">AIDS Behav</source>. <year>2018</year>;<volume>22</volume>(<issue>7</issue>):<fpage>2334</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">29336004</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0046">
                <label>46</label>
                <mixed-citation publication-type="miscellaneous" id="jia225720-cit-0046"><collab collab-type="authors">Confirm Biosciences</collab>
. <article-title>DrugConfirm Advanced Urine Drug Test Cups in Bulk | 10 Panel Drug Test</article-title> [Internet]. [cited 2020 Sep 9]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.confirmbiosciences.com/products/urine-drug-test-cups/drugconfirm-advanced-drug-test-cup/">https://www.confirmbiosciences.com/products/urine‐drug‐test‐cups/drugconfirm‐advanced‐drug‐test‐cup/</ext-link>
</mixed-citation>
              </ref>
              <ref id="jia225720-bib-0047">
                <label>47</label>
                <mixed-citation publication-type="book" id="jia225720-cit-0047"><string-name><surname>Sobell</surname><given-names>LC</given-names></string-name>, <string-name><surname>Sobell</surname><given-names>MB</given-names></string-name>. <chapter-title>Timeline follow‐back</chapter-title>. In: <person-group person-group-type="editor"><string-name><surname>Litten</surname><given-names>RZ</given-names></string-name></person-group>, <person-group person-group-type="editor"><string-name><surname>Allen</surname><given-names>JP</given-names></string-name></person-group>, editors. <source xml:lang="en">Measuring alcohol consumption</source>. <publisher-name>Springer</publisher-name>; <year>1992</year>. p. <fpage>41</fpage>–<lpage>72</lpage>.</mixed-citation>
              </ref>
              <ref id="jia225720-bib-0048">
                <label>48</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0048"><string-name><surname>Rounsaville</surname><given-names>BJ</given-names></string-name>, <string-name><surname>Carroll</surname><given-names>KM</given-names></string-name>, <string-name><surname>Onken</surname><given-names>LS</given-names></string-name>. <article-title>A stage model of behavioral therapies research: getting started and moving on from stage I</article-title>. <source xml:lang="en">Clin Psychol Sci Pract</source>. <year>2001</year>;<volume>8</volume>(<issue>2</issue>):<fpage>133</fpage>–<lpage>42</lpage>.</mixed-citation>
              </ref>
              <ref id="jia225720-bib-0049">
                <label>49</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0049"><string-name><surname>Freedland</surname><given-names>KE</given-names></string-name>. <article-title>Pilot trials in health‐related behavioral intervention research: problems, solutions, and recommendations</article-title>. <source xml:lang="en">Health Psychol</source>. <year>2020</year>;<volume>39</volume>(<issue>10</issue>):<fpage>851</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">32614197</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0050">
                <label>50</label>
                <mixed-citation publication-type="book" id="jia225720-cit-0050"><string-name><surname>Raudenbush</surname><given-names>SW</given-names></string-name>, <string-name><surname>Bryk</surname><given-names>AS</given-names></string-name>. <source xml:lang="en">Hierarchical linear models: applications and data analysis methods</source>, vol. <volume>1</volume>. <publisher-loc>Thousand Oaks, CA</publisher-loc>: <publisher-name>Sage Publications</publisher-name>; <year>2002</year>.</mixed-citation>
              </ref>
              <ref id="jia225720-bib-0051">
                <label>51</label>
                <mixed-citation publication-type="book" id="jia225720-cit-0051"><string-name><surname>Chakraborty</surname><given-names>H</given-names></string-name>, <string-name><surname>Gu</surname><given-names>H</given-names></string-name>. <source xml:lang="en">A mixed model approach for intent‐to‐treat analysis in longitudinal clinical trials with missing values</source>. <publisher-loc>NC</publisher-loc>: <publisher-name>Research Triangle Park</publisher-name>; <year>2009</year>.</mixed-citation>
              </ref>
              <ref id="jia225720-bib-0052">
                <label>52</label>
                <mixed-citation publication-type="miscellaneous" id="jia225720-cit-0052"><article-title>SAS Enterprise Miner</article-title>. Cary, NC: SAS Institute Inc.; <year>2013</year>.</mixed-citation>
              </ref>
              <ref id="jia225720-bib-0053">
                <label>53</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0053"><string-name><surname>Degenhardt</surname><given-names>L</given-names></string-name>, <string-name><surname>Glantz</surname><given-names>M</given-names></string-name>, <string-name><surname>Evans‐Lacko</surname><given-names>S</given-names></string-name>, <string-name><surname>Sadikova</surname><given-names>E</given-names></string-name>, <string-name><surname>Sampson</surname><given-names>N</given-names></string-name>, <string-name><surname>Thornicroft</surname><given-names>G</given-names></string-name>, et al. <article-title>Estimating treatment coverage for people with substance use disorders: an analysis of data from the World Mental Health Surveys</article-title>. <source xml:lang="en">World Psychiatry</source>. <year>2017</year>;<volume>16</volume>(<issue>3</issue>):<fpage>299</fpage>–<lpage>307</lpage>.<pub-id pub-id-type="pmid">28941090</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0054">
                <label>54</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0054"><string-name><surname>Sethi</surname><given-names>AK</given-names></string-name>, <string-name><surname>Celentano</surname><given-names>DD</given-names></string-name>, <string-name><surname>Gange</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Moore</surname><given-names>RD</given-names></string-name>, <string-name><surname>Gallant</surname><given-names>JE</given-names></string-name>. <article-title>Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance</article-title>. <source xml:lang="en">Clin Infect Dis</source>. <year>2003</year>;<volume>37</volume>(<issue>8</issue>):<fpage>1112</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">14523777</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0055">
                <label>55</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0055"><string-name><surname>Orrell</surname><given-names>C</given-names></string-name>, <string-name><surname>Cohen</surname><given-names>K</given-names></string-name>, <string-name><surname>Leisegang</surname><given-names>R</given-names></string-name>, <string-name><surname>Bangsberg</surname><given-names>DR</given-names></string-name>, <string-name><surname>Wood</surname><given-names>R</given-names></string-name>, <string-name><surname>Maartens</surname><given-names>G</given-names></string-name>. <article-title>Comparison of six methods to estimate adherence in an ART‐naïve cohort in a resource‐poor setting: which best predicts virological and resistance outcomes?</article-title><source xml:lang="en">AIDS Res Therapy</source>. <year>2017</year>;<volume>14</volume>(<issue>1</issue>):<fpage>1</fpage>.</mixed-citation>
              </ref>
              <ref id="jia225720-bib-0056">
                <label>56</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0056"><string-name><surname>Safren</surname><given-names>SA</given-names></string-name>, <string-name><surname>O'Cleirigh</surname><given-names>C</given-names></string-name>, <string-name><surname>Tan</surname><given-names>JY</given-names></string-name>, <string-name><surname>Raminani</surname><given-names>SR</given-names></string-name>, <string-name><surname>Reilly</surname><given-names>LC</given-names></string-name>, <string-name><surname>Otto</surname><given-names>MW</given-names></string-name>, et al. <article-title>A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT‐AD) in HIV‐infected individuals</article-title>. <source xml:lang="en">Health Psychol</source>. <year>2009</year>;<volume>28</volume>(<issue>1</issue>):<fpage>1</fpage>.<pub-id pub-id-type="pmid">19210012</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0057">
                <label>57</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0057"><string-name><surname>Safren</surname><given-names>SA</given-names></string-name>, <string-name><surname>O'Cleirigh</surname><given-names>CM</given-names></string-name>, <string-name><surname>Bullis</surname><given-names>JR</given-names></string-name>, <string-name><surname>Otto</surname><given-names>MW</given-names></string-name>, <string-name><surname>Stein</surname><given-names>MD</given-names></string-name>, <string-name><surname>Pollack</surname><given-names>MH</given-names></string-name>. <article-title>Cognitive behavioral therapy for adherence and depression (CBT‐AD) in HIV‐infected injection drug users: a randomized controlled trial</article-title>. <source xml:lang="en">J Consult Clin Psychol</source>. <year>2012</year>;<volume>80</volume>(<issue>3</issue>):<fpage>404</fpage>.<pub-id pub-id-type="pmid">22545737</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0058">
                <label>58</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0058"><string-name><surname>Safren</surname><given-names>SA</given-names></string-name>, <string-name><surname>Bedoya</surname><given-names>CA</given-names></string-name>, <string-name><surname>O'Cleirigh</surname><given-names>C</given-names></string-name>, <string-name><surname>Biello</surname><given-names>KB</given-names></string-name>, <string-name><surname>Pinkston</surname><given-names>MM</given-names></string-name>, <string-name><surname>Stein</surname><given-names>MD</given-names></string-name>, et al. <article-title>Cognitive behavioural therapy for adherence and depression in patients with HIV: a three‐arm randomised controlled trial</article-title>. <source xml:lang="en">Lancet HIV</source>. <year>2016</year>;<volume>3</volume>(<issue>11</issue>):<fpage>e529</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="pmid">27658881</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0059">
                <label>59</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0059"><string-name><surname>Musyimi</surname><given-names>CW</given-names></string-name>, <string-name><surname>Mutiso</surname><given-names>VN</given-names></string-name>, <string-name><surname>Ndetei</surname><given-names>DM</given-names></string-name>, <string-name><surname>Unanue</surname><given-names>I</given-names></string-name>, <string-name><surname>Desai</surname><given-names>D</given-names></string-name>, <string-name><surname>Patel</surname><given-names>SG</given-names></string-name>, et al. <article-title>Mental health treatment in Kenya: task‐sharing challenges and opportunities among informal health providers</article-title>. <source xml:lang="en">Int J Ment Health Syst</source>. <year>2017</year>;<volume>11</volume>:<fpage>45</fpage>.<pub-id pub-id-type="pmid">28775764</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0060">
                <label>60</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0060"><string-name><surname>Jack</surname><given-names>HE</given-names></string-name>, <string-name><surname>Oller</surname><given-names>D</given-names></string-name>, <string-name><surname>Kelly</surname><given-names>J</given-names></string-name>, <string-name><surname>Magidson</surname><given-names>JF</given-names></string-name>, <string-name><surname>Wakeman</surname><given-names>SE</given-names></string-name>. <article-title>Addressing substance use disorder in primary care: the role, integration, and impact of recovery coaches</article-title>. <source xml:lang="en">Substance Abuse</source>. <year>2018</year>;<volume>39</volume>(<issue>3</issue>):<fpage>307</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">28991516</pub-id></mixed-citation>
              </ref>
              <ref id="jia225720-bib-0061">
                <label>61</label>
                <mixed-citation publication-type="journal" id="jia225720-cit-0061"><string-name><surname>Miler</surname><given-names>JA</given-names></string-name>, <string-name><surname>Carver</surname><given-names>H</given-names></string-name>, <string-name><surname>Foster</surname><given-names>R</given-names></string-name>, <string-name><surname>Parkes</surname><given-names>T</given-names></string-name>. <article-title>Provision of peer support at the intersection of homelessness and problem substance use services: a systematic “state of the art” review</article-title>. <source xml:lang="en">BMC Public Health</source>. <year>2020</year>;<volume>20</volume>(<issue>1</issue>):<fpage>641</fpage>.<pub-id pub-id-type="pmid">32381086</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
